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ABSTRACT 
INTRODUCTION 
Chronic Obstructive Pulmonary Disease (COPD) people suffer from severe 
physical impairments, which often elicit significant physiological distress and impact 
their quality of life. The Global Initiative for Chronic Obstructive Lung Disease defined 
Chronic Obstructive Pulmonary Disease as airflow limitation that tends to not be fully 
reversible and which is usually both progressive and associated with an abnormal 
inflammatory response of the lungs to noxious particles or gases. 
STATEMENT OF THE PROBLEM 
A study to evaluate the efficacy of selected pulmonary rehabilitation programme 
on health wellbeing among patients with COPD at Vadamalayan Hospital in Madurai. 
OBJECTIVES 
Objectives of the study were; 
1. To assess the pre test and post test health wellbeing among patients with COPD 
in the control and experimental group. 
2. To determine the efficacy of selected pulmonary rehabilitation programme on 
health wellbeing among patients with COPD by comparing the pre test and post 
test scores within and between the control and experimental group. 
3. To associate the health wellbeing of the patients with COPD with their 
demographic and clinical variables.  
 
 
 
  
MATERIALS AND METHOD 
In this study, quasi experimental pre-test and post- test control group design was 
adopted. The researcher has chosen Vadamalayan Hospital from Madurai, Tamil Nadu as 
the control and experimental group for the study. The sample comprised of 60 patients 
who were diagnosed with COPD at Vadamalayan Hospital in Madurai, among which 30 
patients were assigned in the control group and 30 patients were in the experimental 
group. The samples were recognized based on the inclusion criteria and selected by non 
probability convenient sampling technique. The patients were subjected to assess both 
pre test and post test. 
RESULTS 
The data obtained was analyzed using descriptive and inferential statistics. The 
paired ‘t’ test of the health well-being score within the control group was 0.03 and               
p= 0.97. in experimental group, the paired ‘t’ test of the health well-being score was 0.52 
and p > 0.05. The unpaired ‘t’ test of the health well-being score between control and 
experimental group was 15.07 and p = 0.001. 
CONCLUSION 
The study results revealed that, there was a statistical significant difference in the 
health well-being among patients with COPD in the control and experimental group. The 
study concluded that the selected pulmonary rehabilitation programme (Respiratory 
muscle exercise, Muscle strengthening and Smoking cessation) was highly effective in 
improving the health wellbeing among patients with COPD. Hence, it is clearly judged 
that the health wellbeing has improved to in the experimental group after implementing 
pulmonary rehabilitation programme among patients with COPD. 
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CHAPTER – I 
INTRODUCTION 
Courage doesn’t always roar. Sometimes courage is the quiet voice at the end of the 
day saying, ‘I will try again tomorrow’ 
- Mary Anne Radmacher 
Chronic Obstructive Pulmonary Disease (COPD) caused by long-term 
exposure to irritating gases or particulate matter, most often from cigarette smoke. 
People with COPD are at increased risk of developing heart disease, lung cancer and a 
variety of other conditions. It is a crucial health issue and ranks fifth in the global 
burden of disease. Even though the disease is identified by the symptoms of 
intensified respiratory manifestations and decline in functional status, exacerbation 
gives rise to the substantial threat for morbidity and early mortality. 
Worldwide, 210 million people are approximately to have COPD. It is also 
expected to be the third leading cause of death worldwide by 2020. Both in 
developing as well as in developed countries the prevalence is increasing, might be 
due to the tobacco consumption. Exacerbations of COPD are characterized by 
increased dyspnea and poor quality of life. 
COPD is characterized by persistent and usually progressive airflow 
limitation, which occurs in response to long-term exposure to noxious particles or 
glass (e.g. air pollution or smoking). These irritants cause an inflammatory response 
in the lungs, leading to shortness of breath, coughing and sputum production. In 
addition, in the majority of cases, acute exacerbation of COPD is triggered by 
respiratory tract infections. Diagnosis of COPD severity is based on symptoms, 
exacerbation frequency and the degree of airflow limitation as assessed by pulmonary 
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function testing. Treatment of COPD involves lifestyle modifications as well as the 
use of pharmacotherapy which includes bronchodilators and corticosteroids for 
exacerbation of COPD. Notably, it is known to be associated with several important 
chronic co morbid diseases such as Hypertension, Cardiovascular disease, Obstructive 
sleep apnea and Type-2 Diabetes Mellitus which were already partially interrelated. 
COPD is a deadly medical condition with under-estimated mortality and 
morbidity rates across the globe. It remains undiagnosed probably because it 
progresses gradually and show signs at a very late stage. The National Commission on 
Macroeconomics and Health has identified India as one of the country mostly affected 
by COPD. The Commission identified about 17 million Indians suffering from COPD 
in 2006, and the numbers are expected to reach 22 million by 2016. According to 
NCMH estimates, COPD is more prevalent in the rural areas of India comparing with 
the urban parts of the country, and the numbers are continuously on increase. 
India is changing - not only in terms of its demographics, urbanization, 
economic profile, pollution but also in terms of its health burden, disease pattern, 
dominant-disease-composition, morbidity and mortality determinants. 
China and India also contributes a significant and growing percentage of 
COPD mortality estimated to be the highest in the world; i.e. more than 64.7 of 
estimated age standardized death rate per 100,000 amongst both sexes in the WHO 
Global InfoBase Updated on 20thJanuary 2011 (India 102.3 and China 131.5). This 
would translate into approximately 556,000 in case of India (>20%) and 1,354,000 
cases in China (about 50%) out of a world total of 2,748,000 annually. 
According to the WHO, 80 million people have moderate to severe COPD 
worldwide, and 3 million people died from COPD in 2005.No treatment to date save 
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smoking cessation has proved to slow the deterioration of lung function. Thus, the 
objectives of treatment have been to decrease the burden of the disease through relief 
of symptoms, improvement of exercise tolerance, and prevention and treatment of 
exacerbations. COPD is a progressive irreversible airway disease characterized by 
emphysema and chronic bronchitis, resulting in breathlessness, cough and sputum. 
The global burden of Diseases study showed that approximately 2.7 million 
deaths from COPD occurred in 2000, due to COPD half of them in the Western 
Pacific Region. About 400,000 deaths occur each year from COPD in industrialized 
countries and this can be expected to rise unless urgent action is taken to control 
leading risk factors, particularly tobacco. In India, the smoking association with 
COPD was reported as 82.3 percent of male patients on an average in an analysis of 
several population studies. Excertional dyspnea often causes patients COPD to 
unconsciously reduce their activities of daily living to reduce the intensity of their 
distress. The reduction in activities of daily living leads to reconditioning which, in 
turn, further increases dyspnea. Both dyspnea and fatigue are important factors 
affecting health-related quality of life. Though medications are used to control the 
symptoms of COPD, but it will not give permanent cure. Performing breathing 
exercises reduces the frequent dyspnea and improves relaxation and pulmonary 
function. Limited empirical documentation exists to support the effectiveness of a 
nurse managed rehabilitation programme for older patients with COPD. Pulmonary 
rehabilitation programme helps to reduce shortness of breath, increasing exercise 
tolerance, decrease the frequency and duration of hospital admissions, socio economic 
gains from reduced hospitalizations, a reduction in anxiety, depression and somatic 
concern, the return of patients to employment and the establishment of a better quality 
of life. 
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Emphysema and chronic bronchitis are the two most common conditions that 
contribute to COPD. Chronic bronchitis is inflammation of the lining of the bronchial 
tubes, which carry air to and from the air sacs (alveoli) of the lungs. It's characterized 
by daily cough and mucus (sputum) production. Emphysema is a condition in which 
the alveoli at the end of the smallest air passages (bronchioles) of the lungs are 
destroyed as a result of damaging exposure to cigarette smoke and other irritating 
gases and particulate matter. COPD is treatable. With proper management, most 
people with COPD can achieve good symptom control and quality of life, as well as 
reduced risk of other associated conditions. The pulmonary rehabilitation programme 
improves the health wellbeing of the patients. 
SIGNIFICANCE AND NEED FOR THE STUDY 
In the United states approximately 6.3% of the adult population. In 2011, there 
were approximately 730,000 hospitalizations in United States for COPD. COPD is the 
third leading cause of death in the United States, affecting an estimated 15 million 
Americans. 
In England, an estimated 0.84 million people of 50 million have a diagnosis of 
COPD. This translates into approximately one person in 59 receiving a diagnosis of 
COPD.  
WHO estimates suggest that 90% of COPD related deaths occur in low and 
middle income countries. India and China constitute 33% of the total human 
population and account for 60% of the global COPD mortality is likely to grow by 
160% in the Southeast Asian region in the coming decades. Globally the increase in 
the burden of COPD has been attributed to cigarette smoking among men and women, 
longer survival of populations, and high levels of air pollution, particularly in 
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developing countries. India is a large country comprising of people with varying socio 
demographic profiles, cultural practices and ethnicities. Hence the risk factors for 
COPD are also likely to be different across various states and regions in India. 
According to a global survey, morality rate due to COPD is the highest in 
India, and a few African countries. India has perhaps the highest percentage of COPD 
related mortality, and the number is growing constantly. The age standardized 
mortality rate is found to be around 65 per 100,000 for both male and female in India. 
This is around 20 percent of the global total per year. 
COPD is reported to have an estimated disease burden of 210 million people 
worldwide. Globally COPD was the fourth leading cause of death (5.1%) in 2004 and 
is projected to occupy the third position (8.6%) in 2030. Also COPD is a major cause 
of chronic morbidity. It was ranked eleventh in 2002 and is projected to rise to 
seventh place in 2030. The prevalence of COPD in adults ranges between 0.2% in 
Japan and 37% in USA. The burden of obstructive lung disease group recently 
reported an average global COPD prevalence of 10.1% with wide variations across 
the participating countries. Additionally, COPD contributes to the economic burden 
faced by patients as well as the healthcare infrastructure in the country, incurring 2-4 
fold higher costs compared with asthma and ischemic heart disease. Together COPD, 
asthma and other respiratory disease are the second (10.2%) leading cause of death in 
the population aged 25-69 years in India, as reported in 2001-2003 and they account 
for 3% of disability adjusted life years lost of the chronic respiratory disease, COPD 
accounts for about 500,000 deaths in India, which is more than four times the number 
of people who die due to COPD in USA and Europe. A recently completed 
nationwide questionnaire – based study estimated the prevalence of COPD at 3.49% 
in India (ranging from1.1% in Mumbai to 10% in Trivandrum). The spirometry test 
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was not employed for the diagnosis of COPD in this study and it is therefore possible 
that the reported COPD burden could be under estimated. Recently, the burden of 
obstructive lung disease study conducted in Pune, Mumbai and Srinagar reported 
overall COPD prevalence estimates of 6.25%, 6.8% and 10.05% respectively. 
Dr. Pradyut Waghray, Director and senior consultant of Medical Specialties 
Private limited in 2011, says that COPD contributed Rs.35, 000 Cores as economic 
burden and today it is estimated to have reached Rs. 48,000crore. 
Recently, the burden of obstructive lung disease study conducted in Pune, 
Mumbai and Srinagar reported overall COPD prevalence estimates of 6.25%, 6.8% 
and 16.05%, respectively. 
Delhi may be one of the most polluted cities but it faces a marginally lower 
health impacts possibly due to transition from solid fuels.  If calculated in terms of life 
years lost due to air pollution, it lead disabilities like COPD or Heart disease or what 
medical experts call Disability Adjusted Life Years, Delhi had a Disability Adjusted 
Life Years rate of 1890 from air pollution compared to 4308 in Bihar and 4390 in 
Uttar Pradesh. 
During my clinical experience among the COPD patients very often I realized 
that they were not satisfied with the behavior of health care and no proper advocacy 
regarding the health, environment and social relationship were provided, which made 
a low impact in their health well-being. Hence, I felt that nowadays commonly the 
COPD patients were mostly affected in all the aspects of health dimensions like 
Physical, Social, Psychological, Intellectual and Spiritual components, which lead to 
poor health well-being. So, the researcher decided to do this study on selected 
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pulmonary rehabilitation programme to improve the level of health well-being among 
COPD patients. 
STATEMENT OF THE STUDY 
A study to evaluate the efficacy of selected pulmonary rehabilitation 
programme on health well-being among patients with COPD in Vadamalayan 
Hospital at Madurai. 
OBJECTIVES OF THE STUDY 
1. To assess the pre test and post test health well-being among patients with 
COPD in the control and experimental group. 
2. To determine efficacy of selected pulmonary rehabilitation programme on 
health well-being among patients with COPD by comparing pre test and post 
test scores within and between the control and experimental group. 
3. To associate the health well-being of the patients with COPD with their 
demographic and clinical variables. 
HYPOTHESIS 
H1- There is a significant difference in the pre- test and post- test of selected 
pulmonary rehabilitation scores of health wellbeing among COPD patients in the 
control and experimental group. 
H2- The mean post test score of health wellbeing is significantly higher in the 
patients with COPD who were exposed to selected pulmonary rehabilitation 
programme than the patients those who were not exposed to selected pulmonary 
rehabilitation programme. 
H3- There is a statistical significant association between health wellbeing with 
their demographic and clinical variables in the both control and experimental group. 
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OPERATIONAL DEFINITION 
Efficacy 
In this study, it refers to the desired outcome of the pulmonary rehabilitation in 
terms of health well-being outcomes among COPD patients, as elicited through the 
difference between the pre and post score on pulmonary rehabilitation programme in 
experimental group. 
Health Well-being 
 In this study, it refers to the harmonious function of diverse and 
interconnected dimensions of human being such as physical, psychological, social, 
intellectual and spiritual aspects. 
Selected pulmonary rehabilitation 
In this study, it refers to the multidimensional continuum of programme in 
which it is focused as follows, 
1) Respiratory muscle exercise – It consists of Pursed lip, diaphragmatic and 
deep breathing exercise to improve lung capacity. 
2) Muscle strengthening exercise -.It consists of front thigh, shoulder, palm 
down forearm, palm up, neck, leg lift, knee lift, knee bend, heel lift, leg 
extension stretching which helps to manage the chronic diseases. 
3) Smoking cessation – It enables the loss of breath to be stabilized and reduces 
the frequency of coughing and expectoration. 
Patient with COPD 
In this study, it refers to the patients who have been diagnosed as COPD with 
the criteria of breathing difficulty without exacerbation on admission. 
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ASSUMPTIONS 
It is assumed that: 
1. The health well-being of the patients with COPD is assumed to be low. 
2. Effect of selected pulmonary rehabilitation programme helps in enhancing the 
health well-being among patients with COPD. 
DELIMITATION 
The findings of the study were delimited to: 
1. COPD patients with high level of well-being level in selected hospitals at 
Madurai. 
2. COPD patients by screening with modified health well-being scale. 
3. A period of 6 weeks. 
PROJECTED OUTCOME 
The findings of the study will help to: 
1. Evaluate the efficacy of selected pulmonary rehabilitation programme among 
patients with COPD in selected hospitals at Madurai. 
2. Determine the effectiveness of selected pulmonary rehabilitation programme 
by nurses to the needed population. 
3. Improve the health well-being among patients with COPD. 
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CHAPTER – II 
REVIEW OF LITERATURE 
 
This chapter deals with the review relevant to the present study. It is presented 
under the following headings. 
1. Studies related to pulmonary rehabilitation programme. 
2. Studies related to chronic obstructive pulmonary disease. 
3. Studies related to pulmonary rehabilitation programme on health wellbeing 
among COPD patients. 
STUDIES RELATED TO PULMONARY REHABILITATION PROGRAMME 
Renata Pires et al., 2013 conducted a study on Smoking Cessation 
Interventions for COPD. The aim of this systematic review is to establish the most 
effective stop smoking intervention approach for smokers with COPD. The search 
strategy included the electronic databases MEDLINE, EMBASE,AMED, PsycINFO, 
DARE, Cochrane Library, and CINAHL, between January 2006 and January 
2010.References of the included studies were also screened for additional papers, and 
further hand searches were conducted. The selection criteria included randomized 
controlled trials or quasi-randomized controlled trials with at least one subject group 
diagnosed with COPD. Two independent reviewers reviewed the included studies, 
using a quality assessment form developed from the selection criteria. Divergence of 
quality assessment scores was resolved by the 2 reviewers agreeing on a score. The 
4studies selected indicate that psychosocial interventions combined with 
pharmacotherapy are effective in smoking cessation at 12 months post-intervention, 
although the effect is not statistically significant, due to small sample size and 
heterogeneity between the studies (odds ratio 2.35, 95% CI 0.25–21.74,).However, 
11 
 
despite this medium effect size, due to a lack of universal use of pharmacotherapies in 
most of the studies, it makes a definitive comparison of efficacy difficult to 
determine. This review also shows the effectiveness of psychosocial treatment for 
people with or without COPD symptoms at 12 months, although the effect of disease 
severity is not clear. This review also highlights the difficulty of maintaining 
attendance at community-based locations, compared to acute or research settings. 
 Anna Norweg et al., 2008 conducted a qualitative study was to analyze 
participants’ perceptions of a pulmonary rehabilitation programme, which combined 
occupational therapy with physical therapy. Semi-structured interviews were used to 
collect data from four adults with chronic obstructive pulmonary disease (COPD) who 
attended an outpatient pulmonary rehabilitation programme in New York City. 
Features of the occupational therapy programme reported to be valuable were 
biofeedback and clinician support. Participants reported more control of dyspnea, 
improved mental health and confidence in performing daily activities, less fatigue, 
more physically active lifestyles and hope for the future. Limitations of the study were 
that participants were interviewed only once and themes were not verified with 
participants. The study results also cannot be generalized. Further research is needed 
to evaluate the effectiveness of occupational therapy in promoting self-management 
and coping skills and restoring occupational performance in adults with COPD. 
Participants’ responses provide additional support for developing cognitive-
behavioral protocols in occupational therapy and measuring their effectiveness in 
relieving anxiety symptoms and promoting dyspnea management. 
 Nicholas S. Hill, 2006 conducted a pulmonary rehabilitation programs use 
multidisciplinary teams to optimize physical and social functioning of patients with 
chronic respiratory impairment. These programs provide rehabilitation in inpatient, 
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outpatient, or home settings, using at least three sessions weekly (one may be 
unsupervised) foe at least 6 weeks. The programs usually consist of exercise training, 
education and psychosocial/behavioral components. Upper extremity exercises and 
instruction on breathing technique are included in rehabilitation programs and reduce 
dyspnea, but the contribution of these to improved functional capacity remains 
unproven. Decreases in the sensation of dyspnea, increased functional exercise 
capacity, and enhanced quality of life of patients with COPD are established benefits 
of pulmonary rehabilitation. Evidence is lacking for the efficacy of rehabilitation for 
patients with non- COPD causes of pulmonary impairment, but many of these patients 
probably benefit. Despite the availability of strong evidence to support the efficacy of 
pulmonary rehabilitation programs in patients with severe COPD, third-party 
reimbursement policies have been inconsistent. Nonetheless, enrollment in a 
pulmonary rehabilitation program is encouraged for all appropriate candidates with 
chronic respiratory impairment, particularly for those with severe COPD. 
 Ralph J. H. Koppers et al., 2006 conducted a study on impaired exercise 
tolerance is frequently observed in patients with COPD. Respiratory muscle 
endurance training (RMET) by means of normocapnic hyperpnea can be used to 
improve respiratory muscle function and probably exercise capacity. RMET is not 
applied on a large scale because complicated equipment is needed to maintain carbon 
dioxide homeostasis during hyperpnea, which can also be done by enlarging the dead 
space of the ventilator system by breathing through a tube. Therefore, tube breathing 
might be a new, inexpensive method for home-based RMET. The aim of this study 
was to assess whether home-based RMET by means of tube breathing improves 
endurance exercise performance in patients with COPD. We randomized 36 patients 
with moderate-to-severe COPD to RMET by paced tube breathing (n _ 18) or sham 
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training (control, n _ 18). Both groups trained twice daily for 15 min,7 days per week, 
for 5 weeks. Patients receiving RMET showed significant improvements in endurance 
exercise capacity (constant-load exercise on cycle ergometry; 18 min vs 28 min,               
p < 0.001), in perception of dyspnea (Borg score; 8.4 vs 5.4, p < 0.001), and 
respiratory muscle endurance capacity(sustainable inspiratory pressure; 25 cm H2O vs 
31 cm H2O, p _ 0.005). Quality of life (chronic respiratory disease questionnaire) also 
improved (78.7 to 86.6, p _ 0.001). The control group showed no significant changes. 
Home-based RMET by means of tube breathing leads to a significant improvement of 
endurance exercise capacity, a reduction in perception of dyspnea, and an 
improvement in quality of life in patients with moderate-to-severe COPD. 
 Hale Karapola et al., 2005 conducted a study on The effects of an outpatient 
pulmonary rehabilitation program on psychological morbidity (anxiety and depressive 
symptoms) were examined in patients with chronic obstructive pulmonary disease 
(COPD).The 26 rehabilitation patients with COPD were compared with 19 control 
patients with COPD similar in age, gender, COPD severity and other variables. Initial 
assessment included lung function testing, health status, exercise tolerance, dyspnea 
intensity and psychiatric interviews using Hamilton depression rating scale(HAM-D) 
and Hamilton anxiety rating scale (HAM-A). A pulmonary rehabilitation program 
was carried out during the following 2 months; psychiatric interviews and 
measurements of health status, exercise tolerance and dyspnea intensity were done 
again on completion of the study at 2 months. There was a decrease in HAM-A scores 
in the rehabilitation group and the decrease was statistically significant (P ¼ 0:010). 
On the contrary the HAM-A scores did not change in control group. The decrease in 
HAM-A scores in rehabilitation group was also statistically significant compared with 
the control group (P ¼ 0:042).There was no significant difference in HAM-D scores 
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within the two groups and also there was no significant difference between the two 
groups in HAM-D scores. The health status, exercise tolerance and dyspnea intensity 
improved significantly in the rehabilitation group compared to the control group. This 
study shows that our outpatient rehabilitation program leads to a benefit in anxiety 
and depressive symptoms in COPD patients. The benefit was especially significant in 
anxiety symptoms. In addition to the improvement in psychological symptoms, the 
health status, exercise tolerance and dyspnea intensity were also significantly 
improved in COPD patients who underwent the rehabilitation program. This 
outpatient-based rehabilitation program was well accepted by the patients. The 
relatively simple design of the program makes it feasible independently of expensive 
equipment. 
 Maria Rosa Guell Rous et al, 2004Pulmonary rehabilitation (PR) has been 
shown to improve dyspnea, exercise capacity and health-related quality of life in 
patients with COPD. PR has also shown benefits in diseases other than COPD but the 
level of evidence is lower. The fundamental components of pulmonary rehabilitation 
programs are muscle training, education and chest physiotherapy. Occupational 
therapy, psychosocial support and nutritional intervention should also be considered. 
Home programs have been shown to be as effective as hospital therapy. The duration 
of rehabilitation programs should not be less than 8 weeks or 20 sessions. Early 
initiation of PR, even during exacerbations, has proven safe and effective. The use of 
oxygen or noninvasive ventilation during training is controversial and dependent on 
the patients situation. At present, the best strategy for maintaining the benefits of PR 
in the long term is unknown. Longer PR programs or telemedicine could play a key 
role in extending the results obtained. 
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Whelan TP, et al., 2004 conduct a study on little is known about gastro 
esophageal reflux disease (GERD) in patients with chronic obstructive pulmonary 
disease (COPD); however, GERD is common in many other chronic respiratory 
diseases. This study evaluated the prevalence, presentation, and predictors of GERD 
based on proximal and distal esophageal pH monitoring in patients with severe 
COPD. The overall prevalence of GERD was 57%, but only one-third reported 
heartburn or acid regurgitation during the study. Only higher body mass index was 
predictive of reflux on regression analysis. The authors concluded that while GERD is 
common in patients with COPD, most are asymptomatic and have a relatively high 
prevalence of isolated abnormal proximal reflux. 
 Dick et al., 1997 studied 11 hypoxemic COPD patients. The ventilator 
responses to hypercapnia and hypoxia were measured using evaluated re-breathing 
techniques. They have concluded that oxygen induced high carbon dioxide levels does 
not indicate any respiratory failure in all these 11 patients. Therefore it was proved 
that oxygen induced changes in the respiratory drive is not due to hypoxic drive in 
COPD patients.  
Studies related to chronic obstructive pulmonary disease. 
Mohamed Saleem et al., 2017 conduct a study on the prevalence of chronic 
obstructive pulmonary disease. Burden of disease estimation is important for decision 
making, planning, prioritising and allocating funds. It has been found that the recent 
data on prevalence of COPD is less in south India, especially Tamil Nadu. Hence this 
study was undertaken in order to estimate the prevalence of COPD in Madurai among 
adults and its association with socio demographic variables. This is a community 
based cross-sectional study done in Kallendiri block of Madurai district with adults 
aged >30 years of both the sexes as study population. Sample size was 480. Using 
16 
 
cluster sampling method, study participants were interviewed with semi-structured 
questionnaire and peak expiratory flow rate was measured using peak flow meter. 
Prevalence of COPD was 22.1% among the study population. Males (39.2%) had 
higher prevalence than females (12.2%). COPD prevalence was significantly higher 
among increasing age, male sex, illiteracy, low BMI, smokers, inadequate ventilation 
and those using biomass fuels for cooking. This study has established the fact that 
COPD is highly prevalent among adults in rural area. For practitioners, the results call 
for a high index of suspicion of COPD among >30 years with substantial exposure to 
risk factors. For health policy makers, the results of the current study urge for the 
development of COPD prevention programs failing which the burden of COPD might 
result in increased mortality, morbidity and economic burden. 
Prabu Rajkumar et al., 2017 conducted a  cross-sectional study will be 
undertaken among the populations of sub-urban areas of Chennai and Shillong cities, 
which represent the Southern and Northeastern regions of India. We will collect data 
on socio demographic variables, economic characteristics, risk factors of COPD and 
co-morbidities. The Global Initiative for Obstructive Lung Disease (GOLD) and 
Global Initiative for Asthma (GINA) definitions will be used for the diagnosis of 
COPD and asthma. Data will be analyzed for estimation of the prevalence of COPD, 
asthma and associated factors. 
Amanda R. van Buul et al., 2016 conducted a study on Morning symptoms 
are common in chronic obstructive pulmonary disease (COPD). Many COPD patients 
consider the morning as the most troublesome part of the day, in which they 
experience more symptoms and physical activity limitations. To systematically report 
evidence of the association between morning symptoms and physical activity in 
COPD patients, a literature search was conducted using relevant MESH terms and 
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text words in PubMed, Embase, Web of Science, COCHRANE, CINAHL and 
PsycINFO. Quality of the articles was assessed with validated checklists. Eight 
studies were included. Morning symptoms were present in 39.8–94.4%. In                   
37.0–90.6% of all COPD patients, there was an association between physical activity 
and morning symptoms. However, causality could not be proved. Morning symptoms 
were associated with a sedentary lifestyle (p<0.05). Treatment in line with the 
guidelines improved the degree of activity limitations due to morning symptoms 
(p<0.0001). Across all disease stages, COPD patients experience morning symptoms 
which are negatively associated with physical activity. Physicians should consider 
morning symptoms as a treatment goal. Pharmacotherapy may improve the degree of 
activity limitations due to morning symptoms. More objective research should focus 
on symptoms, activity limitations and physical inactivity of COPD patients, especially 
in the morning. 
Antonio Martin et al, 2013 conduct a study to determine the prevalence and 
analyze the most relevant clinical characteristics of three clinical phenotypes of 
COPD: emphysema (type 1), chronic bronchitis (type 2) or COPD-asthma (type 3). 
Observational, multicenter study performed with 331 COPD patients recruited in 
pulmonology outpatient services. The stratification in three phenotypes was 
performed with imaging tests, pulmonary function, and a standardized clinical 
questionnaire. The 43.2% presented an emphysematous phenotype, 44.7% were 
chronic bronchitic and the other 12.1% presented a phenotype showing mixed 
characteristics with asthma. There were no significant differences in the smoking 
level, in the gasometric values or time of disease evolution. Type 1 patients showed 
lower FEV1 values in comparison with types 2 and 3, 46.6% (21.1), 55.2% (21.2) and 
54.4% (21.8), respectively (p < 0.05), and greater levels of dyspnea (p < 0.05). No 
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significant differences were observed in the percentage of patients who had at least 
one exacerbation in the last year (68.8%, 63.9%, 64.9%; p Z 0.25), in the number of 
exacerbations (pZ0.56), in the number of visits to the ER (total and due to COPD), or 
in the number of hospital admittances. Type 2 patients showed a greater prevalence of 
cardiovascular comorbidities and of sleep apnea syndrome (4.9%, 23.6% and 12.5%, 
respectively, p < 0.001). 
 Jean Bourbeau et al., 2013 conducted a study Making collaborative self-
management successful in COPD patients with high disease burden 100 randomly 
selected charts of patients followed in a specialised COPD clinic in 2006 and 2009 
(patients with higher burden of disease) were reviewed. Data on patients’ 
characteristics, COPD severity and exacerbation management were extracted. 
Compared to the 2006 cohort, patients from the 2009 cohort had lower (0.85 L), but 
not statistically significant different FEV1 (L) than the 2006 cohort (0.98 L) and more 
exacerbations (2.6 exacerbations/ ptvs 3. 6 exacerbations/pt, pZ0.03). Despite having 
a higher burden of disease, patients in the 2009 cohort as compared to 2006 had more 
appropriate self-management behaviors  in the event of an exacerbation (60% vs 42%, 
p Z 0.05) and fewer emergency room visits and/or hospital admissions (39% vs 57%, 
pZ0.02). There were more phone calls to the case managers (590 vs 382, p < 0.001) 
and fewer physician office visits (167 vs 179, p Z 0.024). This study of a real life 
situation adds to the current body of literature that a more severe COPD patient 
population can be taught self-management skills in the event of exacerbations, leading 
to fewer health care visits and hospital admissions. 
Mohammed A. Zamzam et al., 2013 conducted a study To study quality of 
life in patients with COPD and to examine its relationship with the severity of the 
disease. Quality of life was determined in 40 COPD patients using the St. George’s 
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Respiratory Questionnaire for COPD patients (SGRQ-C). Mild COPD patients 
differed significantly from other grades of COPD in their total SGRQ-C score, 
symptoms score, activity score and impact score (p 6 0.001). There was a statistically 
significant negative correlation between spirometric data (FEV1, FEV1/FVC, PEFR, 
FEF25–75%) and SGRQ-C score (total score, symptoms score, activity score and 
impact score). There was a statistically significant positive correlation between 
smoking index and both symptoms score and impact score. Quality of life is impaired 
in patients with COPD and it deteriorates considerably with increasing severity of 
disease. Increasing severity of COPD is associated with a significant increase in 
SGRQ-C score. A higher smoking index affects the COPD subjects’ QOL especially 
with patients’ symptoms and impact of disease. Psychological assessment and 
psychiatric consultation are important for improving COPD symptoms, QOL and for 
early detection and treatment of superimposed psychiatric symptoms that could 
worsen COPD condition and seriously affect QOL. 
Shu-Hui Yu et al., 2013 conducted a study to explore the effects of self-
management education on the quality of life of patients living with COPD. Eighty-
four stable or discharged COPD subjects were recruited from April 2011 to January 
2012 following treatment at Beijing Hospital or Peking Union Medical College 
Hospital. Subjects were divided into an intervention group who underwent self-
management education or a control group who received usual care without additional 
education (n ¼ 42 each). The St George’s Respiratory Questionnaire (SGRQ) was 
used to measure quality of life at three and six months. SGRQ impact domain scores 
revealed significant differences between the groups (t¼_2.167, p< 0.05) at three 
months. SGRQ symptom, impact, activity domain and total scores revealed 
significant differences between groups (t¼_3.482 to _2.530, p < 0.05) at six months. 
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A nurse-led, simple, structured self-management education program provided an 
effective method for the management of patients with COPD. 
Mark D. Eisne et al.,2010 conducted a study on novel risk factors and the 
global burden of chronic obstructive pulmonary disease. To evaluate the risk factors 
for COPD besides personal cigarette smoking. We constituted an ad hoc 
subcommittee of the American Thoracic Society Environmental and Occupational 
Health Assembly. An international group of members was invited, based on their 
scientific expertise in a specific risk factor for COPD. For each risk factor area, the 
committee reviewed the literature, summarized the evidence, and developed 
conclusions about the likelihood of it causing COPD. All conclusions were based on 
unanimous consensus. The population-attributable fraction for smoking as a cause of 
COPD ranged from 9.7 to 97.9%, but was less than 80% in most studies, indicating a 
substantial burden of disease attributable to nonsmoking risk factors. On the basis of 
our review, we concluded that specific genetic syndromes and occupational exposures 
were causally related to the development of COPD. Traffic and other outdoor 
pollution, secondhand smoke, biomass smoke, and dietary factors are associated with 
COPD, but sufficient criteria for causation were not met. Chronic asthma and 
tuberculosis are associated with irreversible loss of lung function, but there remains 
uncertainty about whether there are important phenotypic differences compared with 
COPD as it is typically encountered in clinical settings. In public health terms, a 
substantive burden of COPD is attributable to risk factors other than smoking. To 
prevent COPD related disability and mortality, efforts must focus on prevention and 
cessation of exposure to smoking and these other, less well recognized risk factors. 
JA Cramer et al., 2007conducted a study to assess the patterns of persistence 
with the above mentioned inhaled medications. Prescription claims data from the 
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Ontario Drug Benefit Program were analyzed to assess persistence (time to 
discontinuation) and compliance (percentage of days with doses available divided by 
days to last refill) of patients prescribed inhaled medications. Patients were grouped 
as naive (no inhaled medication in the previous year) or experienced (previous or 
current treatment), and by age (18 to 65 years of age and older than 65 years of age). 
Medications included ipratropium, ipratropium plus salbutamol, formoterol, 
formoterol plus budesonide, salmeterol, salmeterol plus fluticasone, and tiotropium. 
The database included 31,368 patients (4888 naive and 26,480 experienced) who were 
prescribed at least one of these medications. Fifteen per cent to 63% of patients 
continued on the index drug for more than six months, which decreased to 7% to 53% 
at 12 months, and 5% to 47% at 18 months. At 12 months, patients taking tiotropium 
had significantly longer persistence compared with other therapies (53% versus 7% to 
30%; all P<0.0001), and fewer switches to alternative medications. Most naive 
patients had significantly shorter treatment persistence than experienced patients for 
all drugs (all P<0.0001), including tiotropium (27% versus 55%, P<0.0001). 
Compliance rates were similar for all drugs (i.e. 76% to 94%) but were highest for 
tiotropium. These data demonstrated that persistence with inhaled treatment was low 
overall, but patients treated with tiotropium remained on therapy significantly longer 
than when treated with other medications, and patients naive to inhaled treatment had 
shorter treatment persistence than experienced patients. 
Ana Maria B Menezes et al., 2005 conducted a prevalence study on COPD 
seem to be increasing low and middle income countries complete information, 
including spirometry was obtained from 963 people in Sao Paulo, 1773 in Santiago, 
1000 in Mexico City, 885 in Montevideo, and 1294 in Caracas. Crude rates of COPD 
ranged from 7.8%(78 of 1000; 95%  CI 5.9-9.7) in Mexico rates to 19.7%(174 0f 885; 
22 
 
17.2-22.2) in Montevideo. After adjustment for key risk factors, the prevalence of 
COPD in Mexico City remained significantly lower than in other cities. 
Brahma Prakash, 2004 conduct a study to  the impact of COPD on activities 
of daily living and quality of life of patients and to correlate the impact with severity 
of disease in the set up of Indian conditions. In this prospective study conducted at a 
tertiary level hospital, stable COPD patients without any other coexisting co-
morbidity were enrolled. The severity of COPD was classified as per GOLD 2006 
guidelines. The quality of life and impact of COPD on activities of daily living was 
assessed using Seattle obstructive lung disease questionnaire translated in local 
language, 6 minutes walk test and visual analog scale for dyspnea. Seventy eight 
patients and 20 controls were enrolled for the study. The scores for physical functions, 
emotional functions, coping skills and treatment satisfaction obtained from 
questionnaire were decreased in COPD patients. The physical function and emotional 
function score, decreased significantly (P < 0.05) when compared from mild through 
moderate, severe and very severe stages of COPD, these scores also correlated 
positively with percent predicted FEV1 values in spirometry (r=0.855 and r = 0.735 
respectively) There was a significant fall in the six minute walk distance as the stage 
of disease progressed. The Visual analog scale score significantly increased (P < 0.05) 
with the stage of COPD. Assessing quality of life and ability to perform activities of 
daily living is also important for assessing the disease severity. 
Dick et al. 1997 studied 11 hypoxemic COPD patients. The ventilator 
responses to hypercapnia and hypoxia were measured using evaluated rebreathing 
techniques. They have concluded that oxygen induced high carbon dioxide levels does 
not indicate any respiratory failure in all these 11 patients. Therefore it was proved 
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that oxygen induced changes in the respiratory drive is not due to hypoxic drive in 
COPD patients. 
Antonio Martin et al, 2013 conduct a study to determine the prevalence and 
analyze the most relevant clinical characteristics of three clinical phenotypes of 
COPD: emphysema (type 1), chronic bronchitis (type 2) or COPD-asthma (type 3). 
Observational, multicenter study performed with 331 COPD patients recruited in 
pulmonology outpatient services. The stratification in three phenotypes was 
performed with imaging tests, pulmonary function, and a standardized clinical 
questionnaire. The 43.2% presented an emphysematous phenotype, 44.7% were 
chronic bronchitic and the other 12.1% presented a phenotype showing mixed 
characteristics with asthma. There were no significant differences in the smoking 
level, in the gasometric values or time of disease evolution. Type 1 patients showed 
lower FEV1 values in comparison with types 2 and 3, 46.6% (21.1), 55.2% (21.2) and 
54.4% (21.8), respectively (p < 0.05), and greater levels of dyspnea (p < 0.05). No 
significant differences were observed in the percentage of patients who had at least 
one exacerbation in the last year (68.8%, 63.9%, 64.9%; p Z 0.25), in the number of 
exacerbations (pZ0.56), in the number of visits to the ER (total and due to COPD), or 
in the number of hospital admittances. Type 2 patients showed a greater prevalence of 
cardiovascular comorbidities and of sleep apnea syndrome (4.9%, 23.6% and 12.5%, 
respectively, p < 0.001). 
Brahma Prakash, 2004 conduct a study to  the impact of COPD on activities 
of daily living and quality of life of patients and to correlate the impact with severity 
of disease in the set up of Indian conditions. In this prospective study conducted at a 
tertiary level hospital, stable COPD patients without any other coexisting co-
morbidity were enrolled. The severity of COPD was classified as per GOLD 2006 
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guidelines. The quality of life and impact of COPD on activities of daily living was 
assessed using Seattle obstructive lung disease questionnaire translated in local 
language, 6 minutes walk test and visual analog scale for dyspnea. Seventy eight 
patients and 20 controls were enrolled for the study. The scores for physical functions, 
emotional functions, coping skills and treatment satisfaction obtained from 
questionnaire were decreased in COPD patients. The physical function and emotional 
function score, decreased significantly (P < 0.05) when compared from mild through 
moderate, severe and very severe stages of COPD, these scores also correlated 
positively with percent predicted FEV1 values in spirometry (r=0.855 and r = 0.735 
respectively) There was a significant fall in the six minute walk distance as the stage 
of disease progressed. The Visual analog scale score significantly increased (P < 0.05) 
with the stage of COPD. Assessing quality of life and ability to perform activities of 
daily living is also important for assessing the disease severity. 
JA Cramer et al., 2007conducted a study to assess the patterns of persistence 
with the above mentioned inhaled medications. Prescription claims data from the 
Ontario Drug Benefit Program were analyzed to assess persistence (time to 
discontinuation) and compliance (percentage of days with doses available divided by 
days to last refill) of patients prescribed inhaled medications. Patients were grouped 
as naive (no inhaled medication in the previous year) or experienced (previous or 
current treatment), and by age (18 to 65 years of age and older than 65 years of age). 
Medications included ipratropium, ipratropium plus salbutamol, formoterol, 
formoterol plus budesonide, salmeterol, salmeterol plus fluticasone, and tiotropium. 
The database included 31,368 patients (4888 naive and 26,480 experienced) who were 
prescribed at least one of these medications. Fifteen per cent to 63% of patients 
continued on the index drug for more than six months, which decreased to 7% to 53% 
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at 12 months, and 5% to 47% at 18 months. At 12 months, patients taking tiotropium 
had significantly longer persistence compared with other therapies (53% versus 7% to 
30%; all P<0.0001), and fewer switches to alternative medications. Most naive 
patients had significantly shorter treatment persistence than experienced patients for 
all drugs (all P<0.0001), including tiotropium (27% versus 55%, P<0.0001). 
Compliance rates were similar for all drugs (i.e. 76% to 94%) but were highest for 
tiotropium. These data demonstrated that persistence with inhaled treatment was low 
overall, but patients treated with tiotropium remained on therapy significantly longer 
than when treated with other medications, and patients naive to inhaled treatment had 
shorter treatment persistence than experienced patients. 
Dick et al. 1997 studied 11 hypoxemic COPD patients. The ventilator 
responses to hypercapnia and hypoxia were measured using evaluated rebreathing 
techniques. They have concluded that oxygen induced high carbon dioxide levels does 
not indicate any respiratory failure in all these 11 patients. Therefore it was proved 
that oxygen induced changes in the respiratory drive is not due to hypoxic drive in 
COPD patients. 
Murray et al.,1996 conducted a study on prevalence of COPD. It is a major 
but neglected public health problem and is a leading cause of death and disability 
worldwide. The World Bank estimates that COPD is responsible for > 29 million 
disability-adjusted life-years (DALYS) and 1 million years of life lost per annum 
around the world. These figures place COPD as the fifth most significant global 
health problem, and COPD is expected to become the third leading cause of death in 
the first quarter of the next century Furthermore, COPD is currently the 12th leading 
cause of disability worldwide and is expected to be the fifth leading cause of disability 
by 2020. 
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Easton et al., 1986 conducted a study on 20 isocapnic hypoxic adults, the 
ventilator responses were recorded. The breathing pattern, respiratory drive and the 
minute ventilation were studied in these individuals. It was concluded that the minute 
ventilation may reduce; the partial pressure of carbon dioxide might increase when 
oxygen is given. 
Studies related to pulmonary rehabilitation programme on health wellbeing 
among chronic obstructive pulmonary disease 
Chithra RA and Janula Raju, 2017 conducted a study to evaluate the 
effectiveness of structured teaching programme regarding respiratory therapy among 
patients with respiratory disorders. Convenient sampling technique was used to select 
the samples. The samples consists of 40 patients with Respiratory disorders. The data 
obtained was analyzed and interpreted in terms of the objectives. The findings of the 
study revealed that there was a marked increase in the overall knowledge score of 
post-test than pre-test score which represents the effectiveness of structured teaching 
programme. The calculated t test value was found to be 17.24 which are highly 
significant at 0.01. Thus the structured teaching programme was effective in 
improving the knowledge of patients with respiratory disorders regarding respiratory 
therapy. On the basis of findings the investigator concluded that STP has improved 
the knowledge of the patients with respiratory disorders. 
Savita Jindal et al., 2017 conducted a study on pulmonary rehabilitation 
improve the well-being of COPD patients experience at a tertiary care hospital in 
Ahmedabad, Gujarat, India. Fifty patients with COPD were included and were 
followed up at 8, 24, 48 and 96 weeks. Patients were taught exercises to strengthen 
the lower limb muscles, breathing exercise along with upper limb exercises. The 
outcomes recorded after 96 week of rehabilitation programme were as follows taught 
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exercises to strengthen the lower limb muscles, breathing exercises along with upper 
limb exercises. The outcomes recorded after 96th week of rehabilitation programme 
were as follows: dyspnea grade at (4.1±1.06 versus 1.6±0.6 with paired ‘t’ test of 
20.8328, p<0.0001), health-related quality-of-life (57.7±11.6 versus 38.7±10.6, ‘t’ test 
75.9631, p<0.0001), forced expiratory volume in one second (FEV1) (43.1±16.0 
versus 40.3±16.0, ‘t’ test19.1064, p<0.0001) FEV1/forced vital capacity (FVC) 
(0.86±0.11 versus 0.80±0.12, ‘t’ test 17.0750, p<0.0001). Pulmonary rehabilitation 
reduces dyspnea, increases the exercise capacity and improves quality of- life, reduces 
frequent exacerbations, thus, improves overall well-being of patients with COPD, 
resulting in reduction of significant cost of health burden on society indirectly. 
 Eleonora Volpato et al., 2015 conducted a study on relaxation techniques for 
people with COPD. COPD people suffer from severe physical impairments, which 
often elicit significant psychological distress and impact their quality of life. This 
meta-analysis aimed to assess evidence from the scientific literature on the effects of 
relaxation techniques. We investigated 9 databases to select 25 RCTs. Studies 
included both inpatients and outpatients with COPD. Both respiratory and 
psychological outcomes were considered. Relaxation techniques showed a little 
positive effect on the value of the percentage of predicted FEV1 (𝑑 = 0.20; 95% Cl: 
0.40–0.01) as well as a slight effect on levels of both the anxiety (𝑑 = 0.26; 95% Cl: 
0.42–0.10) and depression (𝑑 = 0.33; 95% Cl: 0.53–0.13).The higher effect size was 
found in the quality of life value (𝑑 = 0.38; 95% Cl: 0.51–0.24).The assessed quality 
of the studies, based on the PEDro Scale, was generally medium/high. Relaxation 
training can have a moderate impact on both psychological well-being and respiratory 
function, resulting in noticeable improvements in both. Although higher quality 
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research is required, our results sustain the importance of relaxation techniques as a 
tool to manage COPD. 
Kylie Hill et al., 2013, conduct a study the importance of components of 
pulmonary rehabilitation, other than exercise training, in COPD Comprehensive 
pulmonary rehabilitation is an important component in the clinical management of 
people with chronic obstructive pulmonary disease (COPD). Although supervised 
exercise training is considered the cornerstone of effective pulmonary rehabilitation, 
there are many other components that should be considered to manage the 
impairments and symptom burden, as well as the psychosocial and lifestyle changes 
imposed by COPD. These include approaches designed to: facilitate smoking 
cessation, optimize pharmacotherapy,) assist with early identification and treatment of 
acute exacerbations,  manage acute dyspnea,  increase physical activity, improve body 
composition,  promote mental health, facilitate advance care planning and establish 
social support networks. This article will describe these approaches, which may be 
incorporated within pulmonary rehabilitation, to optimize effective chronic disease 
self-management. 
Swati Shah et al., 2013 conducted a study to investigate the muscle strength 
and endurance of upper limbs (UL) in chronic obstructive pulmonary disease 
(COPD). We undertook this study to measure and compare the skeletal muscle 
strength and endurance of UL in COPD patients and age matched healthy controls and 
to study the association between lung function parameters and UL muscle strength 
and endurance. Forty one COPD patients and 45 height and weight matched healthy 
subjects of the same age group were studied. UL skeletal muscle strength and 
endurance were measured using the hand grip dynamometer test. Forced vital capacity 
(FVC), forced expiratory volume in 1 sec (FEV1), forced expiratory flow during           
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25-75% FVC (FEF25-75%) and peak expiratory flow rate (PEFR) were measured. 
The handgrip muscle strength and endurance between the two groups were compared 
and correlations between FVC and FEV1 with muscle strength and endurance were 
analyzed. The mean handgrip strength and mean muscle endurance in COPD patients 
were significantly lesser than the normal subjects in both males and females 
(P<0.001). There was significant positive correlation between muscle strength and 
FVC in males (r2=0.32, P<0.05) and between muscle strength and FEV1 in females 
(r2=0.20, P<0.05). The study showed that the handgrip muscle strength decreases as 
the FVC and FEV1decrease in patients with COPD. Identifying those patients who 
have reduced strength and endurance will allow early interventions targeted at 
improving the quality of life of the patient. 
Fulvio Braido et al, 2011 conducted a observational study COPD patient 
well-Being and its relationship with clinical and patient reported outcomes. 164 
patients, with a mean forced expiratory volume in 1s of 58.5%, were recruited. 40% 
of them had a moderately/severely impaired well-being, not correlated with forced 
expiratory volume in 1 s and the Charlson index value but significantly with the 
Medical Research Council score (p=0.0001) that appeared to be the dominant factor. 
Patients with impaired well-being showed a different illness perception in terms of 
correct identification of symptoms, disease consequences, emotional representation 
and confidence in treatment compared with those having a positive well-being. The 
later presented a lower alexithymia prevalence and a better health status. In order to 
minimize the disease-negative effects on patients lives, assessment of well-being and 
its determine factors, as well as planning specific behavioral, education and 
therapeutic interventions seem to be relevant and useful. 
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Adrinee S Scott et al., 2010 conduct a study on success of pulmonary 
rehabilitation in patients with chronic obstructive pulmonary disease. A chart review 
was performed on patients with a clinical diagnosis of COPD who were referred for 
PR. Success was defined according to clinically important changes in St George’s 
Respiratory Questionnaire scores and/or 6 min walk test distance. The majority of 
subjects were men (58%) with a mean (± SD) age of 69±10 years (n=177). Sixty-two 
per cent of participants had a successful outcome with PR, with proportionally more 
responders noting subjective improvement than objective improvement on a 6 min 
walk test (73% versus 51%). Subjects with poor baseline St George’s Respiratory 
Questionnaire scores tended to improve the most (P=0.011 [ANOVA]). Successful 
participants had a greater forced expired volume in 1 s (1.1 L versus 0.9 L; P<0.05) 
and a lower BODE index (body mass index, airflow obstruction, dyspnea, and 
exercise capacity index) at baseline (9.6 versus 10.3; P<0.05). Success of PR was not 
correlated with age, sex, chronic hypoxemic respiratory failure or other chronic 
conditions. Successful participants were more likely to be compliant and to 
experience fewer adverse events (P≤0.001).Our study reinforced the belief that the 
majority of participants with COPD benefit from PR. Few baseline characteristics 
were predictive of success. Subjectively measured improvement occurred more 
frequently than objectively measured improvement and was greatest in those with the 
poorest baseline values. 
Gosselink 2004 conducted a study the efficacy of breathing techniques aiming 
at improving symptoms of dyspnea and eliciting physiological effects is discussed in 
this paper. In patients with COPD, breathing techniques aim to relieve symptoms and 
ameliorate adverse physiological effects by: 1) increasing strength and endurance of 
the respiratory muscles; 2) optimizing the pattern of thoraco abdominal motion; and 
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3) reducing dynamic hyperinflation of the rib cage and improving gas exchange. 
Evidence exists to support the effectiveness of pursed lips breathing, forward leaning 
position, active expiration and inspiratory muscle training, but not for diaphragmatic 
breathing. Careful patient selection, proper and repeated instruction and control of the 
techniques, and assessment of the effects are necessary. Despite the evidence that 
breathing techniques are effective, several problems need to be resolved. The limited 
evidence for the transfer of the effects of breathing techniques during resting 
conditions to exercise conditions raises several questions. 
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CONCEPTUAL FRAMEWORK 
 The concept is a thought, idea or mental image framed in mind response to 
learning something new. A framework is a basic structure supporting anything. 
(Christenson.j .paula, 2002) 
 In this study the Researcher adopted modified J.W Kenny’s open system 
Model” (1999) as a basis for conceptual framework.  According to J.W Kenny all 
living systems are open and there in continuous exchange of matter, energy and 
information, various degree of interaction, with the environment from which the 
system receives input and gives back output in the form of matter, energy of 
information.  System model consist of 3 phases (i.e.) Input, Throughput, Output. 
INPUT 
 It is the first component of the system in which information, energy, or matter 
that enters a system.  For a system to work well, input should contribute in achieving 
the purpose of the system. 
 In this present study, it is referred as “ pre test” in which collect demographic 
and clinical variable as well as health well-being level in both the groups. 
THROUGHPUT 
A system transforms, creates and organizes the process known as throughput.  
This results in a registration of the orientation.  The matter of energy and information 
continually processed through the system, known as throughput.  Process is the use of 
input energy and information for the maintenance of homeostasis of the system. 
33 
 
In this present study, throughput refers to the process of implementing selected 
pulmonary rehabilitation programme explained to the experimental group. 
OUTPUT 
 A system exports products in a process known as output.  J.W Kenny noted 
after processing the input, system return to output (matter energy, information) to the 
environment. Change is a feature of a process that is observable and return as output 
which should different from that which is entered in the system. 
 In the present study, output refers that evaluating the health wellbeing level 
among patients with COPD.  
FEEDBACK  
 If there is any inadequacy in output, the feedback emphasis to strengthen the 
input and throughput.  In this study, feedback is essential for the individuals health 
wellbeing level. 
 According to theorist, information of environmental responses to the system, 
output is utilized by the system in adjustment, correction and accommodations to the 
interaction with the environment. 
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CHAPTER - III 
METHODOLOGY 
This chapter deals with the description of different steps undertaken by the 
researcher for this study. It includes the research approach, research design, setting of 
the study, population, sample, method of sampling, criteria for sample selection, 
sample size, development and description of the tool, validity and reliability of the 
tool, procedure for data collection, plan for data analysis, pilot study and ethical 
consideration. 
RESEARCH APPROACH 
 In order to fulfill the objectives of this study quantitative approach was 
adopted to evaluate the efficacy of selected pulmonary rehabilitation programme on 
health well-being among patients with COPD at Vadamalayan Hospital in Madurai. 
RESEARCH DESIGN 
 Quasi experimental Pre- test Post- test only control group design was adopted 
to evaluate the efficacy of selected pulmonary rehabilitation programme among 
patients with COPD. It is assessed by the notifications as follows: 
GROUP PRE TEST MANIPULATION  
POST- 
TEST 
Control group O1 - O2 
Experimental group O1 X O2 
 
Keys: 
C- Control group 
E- Experimental group 
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X- Intervention- Selected pulmonary rehabilitation programme. (Respiratory muscle 
exercise, Muscle strengthening exercise and Smoking cessation). 
O1- Pre score in the Control and Experimental group. 
O2- Post score in the Control and Experimental group. 
SCHEMATIC REPRESENTATION OF RESEARCH DESIGN 
 
 
 
 
 
 
 
 
  
  
 
   
 
   
 
 
 
 
Fig.No.3.1 SCHEMATIC REPRESENTATION OF RESEARCH DESIGN 
Setting: Vadamalayan hospital  
Design: Pre- test Post- test control group design (Quasi Experimental study) 
Sample: Patients with known case of COPD 
Sample technique: Non- probability convenience sampling 
Sampling size: 60 patients known case of COPD 
Experimental group: 30  Control group: 30 
undergoing cardiac surgery 
Pre-test Pre-test 
Selected pulmonary 
rehabilitation programme No Intervention 
Post test Post test 
Instrument 
Data Analysis 
- Descriptive statistics 
- Inferential statistics 
Findings and conclusion 
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VARIABLES 
 The present study has the following variables: 
 Independent variable – Selected pulmonary rehabilitation programme. 
 Dependent variable – Health wellbeing among patients with COPD. 
SETTING OF THE STUDY 
 The setting of the study was conducted at Vadamalayan Hospital in Madurai, 
which was 13 kilometers away from our college C. S. I. Jeyaraj Annapackiam College 
of Nursing. It was a 250 bedded multi-specialty hospital with an average of 15 
patients in the medical ward per week. It has health facilities such as emergency unit, 
cardio thoracic unit, intensive care unit, post operative unit, pediatric intensive care 
unit, general male and female unit, oncology unit and dialysis unit. 
POPULATION 
 The target population: All COPD patients who were admitted at various 
Hospitals in Madurai. 
 The accessible population: Patients with COPD at Vadamalayan Hospital in 
Madurai. 
SAMPLE 
 The sample was the patients admitted with COPD who fulfills the inclusion 
criteria at Vadamalayan Hospital in Madurai. 
SAMPLE SIZE 
 In this present study, the samples were patients admitted with COPD was 
selected at Vadamalayan Hospital in Madurai. The sample comprised of 60 COPD 
patients among which 30 people were selected under the category of control group 
38 
 
and remaining 30 people were selected under the category of in the experimental 
group. 
 SAMPLING TECHNIQUE 
 Samples for this study were selected through non probability of convenience 
sampling technique at Vadamalayan Hospital in Madurai. Samples were selected 
based on the sampling criteria. 
CRITERIA FOR SAMPLE SELECTION 
Inclusion criteria 
Patients who 
 have breathing difficulty without exacerbation. 
 have saturation level >90% 
 have limitation of daily activities. 
 were between 21 to 60 years of age. 
 were conscious and well oriented. 
 were able to read Tamil or English. 
 were willing to participate in this study. 
Exclusion criteria 
Patients who  
 have breathing difficulty with exacerbation. 
 have acute breathing difficulty. 
 were able to perform regular breathing exercises or yoga. 
 underwent any surgeries.(Valvular surgeries) 
 have  uncontrolled heart failure, severe lower limb arthritis 
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 have neurologic disorder 
 were not willing to participate. 
 were discomfort with the upper and lower extremities. 
 have saturation level < 90%. 
DESCRIPTION OF THE TOOL 
The structured tool developed by the researcher with the guidance of experts 
opinions, various resources and review of literature. The tools consists of 2 parts: 
PART I 
Section –A: Structured tool to evoke socio demographic data of patients with COPD. 
It consists of demographic variables of the patients include Age in years, 
Gender, Religion, Educational status, Occupation, Income and Type of family. 
Section- B: Structured tool to obtain clinical data of patients with COPD. 
It consists of clinical information of patients include Smoking history,  
Duration of respiratory illness in years, Number of previous hospitalization due to 
acute exacerbation of COPD, Reason for admission, Season of exacerbation, Triggers 
of  exacerbation, Sleep disturbance due to, Comorbidity and Treatment modalities.  
PART II 
- Modified health wellbeing scale consists of the following components: 
I. Physiological health wellbeing – have 10 items with the response 
of 1- all the time, 2- some time and 3- not at all. 
II. Physical health wellbeing – have 5 items with the response of       
1- much difficulty, 2- some difficulty and 3-no difficulty. 
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III. Emotional health wellbeing – have 4 items with the response of   1- 
much difficulty, 2- some difficulty and 3-no difficulty. 
IV. Social health wellbeing – have 4 items with the response of          1- 
much difficulty, 2- some difficulty and 3-no difficulty. 
V. Spiritual health wellbeing – have 2 items with the response of       
1- much difficulty, 2- some difficulty and 3-no difficulty. 
SCORING PROCEDURE 
The efficacy of selected pulmonary rehabilitation programme on health 
wellbeing was measured by the following tool: 
1. Modified Health Wellbeing tool- it consists of 25 questions allotted in the 
modified health wellbeing scale. Each question has 3 response and each 
response were given maximum score of 3 and minimum score 1. Total score 
of 75 was converted to 100%. The score was ranged as follows: 
Health Wellbeing score Classification 
1-33% Distress. 
34-67% Moderate wellbeing. 
68-100% Positive wellbeing. 
VALIDITY AND RELIABILITY OF THE TOOL 
VALIDITY 
Validity of the tool had been determined by experts opinion from different 
fields. Experts evaluated the tool for its clarity, appropriateness, adequacy relevance 
and completeness. Few modifications and suggestions were made as per comments 
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given by experts. The instruments was refined and finalized after establishing the 
validity. Tool was developed in English and checked for language validity. 
RELIABILITY 
 The reliability of the tool was done by test and retest method. The reliability of 
the tool was computed by Spearman coefficient – correlation method r = 0.80 was 
high positive. The modified structured questionnaire was found to be reliable. 
PILOT STUDY 
Pilot study was conducted at Velammal Hospital in Madurai. It was conducted 
among 10 COPD patients after obtaining permission from the concerned authorities. 
Out of 10 samples, each 5 samples in control and experimental group were taken for 
study. Pre-test was carried out for both groups regarding health well-being by using 
modified structured health well-being tools. On the same day after pre-test, patients in 
the experimental group were given selected pulmonary rehabilitation programme. 
Post- test carried out after 5 days by using the same health well-being tools for both 
groups. The study was found to be feasible with regard to time, availability of subjects 
and cooperation of samples. The pilot study revealed that the study was feasible. Data 
was analyzed to find out the suitability of statistics and found to be significant.   
METHOD OF DATA COLLECTION 
The data about the phenomenon under the study was collected from the adult 
clients who have diagnosed as COPD in medical unit of Vadamalayan Hospital, 
Madurai. The period of data collection was 6 weeks. The researcher got permission 
from the administrative authorities after a written requisition. 
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The samples were recognized based on the inclusion criteria and picked up 
with non-probability convenient sampling technique. The sample selected were 60, of 
which 30 samples were allotted in the control group and remaining 30 samples were 
in the experimental group. The samples were selected after the diagnosis. The 
researcher maintained a good rapport with the samples and explained the purpose of 
the study and obtained oral/verbal consent before proceeding with the rehabilitation 
programme. Following week rehabilitation was given only to experimental group in 
two times a day and thrice a week. 
Data collection process 
Period Task 
Control group Experimental group 
Day 1 
 
 
Step  1- Pre test Step 1- 
 Pre test 
 Exposure to selected pulmonary rehabilitation 
programme. 
 
Day 5 
 
Step  2- Post test. 
 
Step 2- Post test. 
 
DATA COLLECTION PROCESS 
The data collection was done separately in the control and experimental 
groups from the Vadamalayan Hospital. The total data collection process was carried 
out in two phases as follows: 
(1)First Phase 
It consists of conduction of pre-test, which was performed as follows: 
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First phase of data collection process. 
GROUP 
FIRST PHASE (Pre-test) 
DAY-1 
CONTROL 
SESSION 1 
NIL 
EXPERIMENTAL 
SESSION 1 
SESSION 3 
 
 1ST SESSION: ORIENTATION 
The researcher oriented about the purpose of the study to the nursing staff and 
the patients in the control and experimental groups. A pre-test gathered by self-
administration of structured questionnaire on demographic variables and clinical 
variables to each sample in the control and experimental groups. The patients were 
categorized according to the inclusion criteria as control and experimental group 
simultaneously and the pre test was done.                   
 
 2ND SESSION: EXPOSURE TO SELECTED PULMONARY 
REHABLITATION PROGRAMME. 
The patients who were diagnosed with COPD in the medical ward were 
selected and the selected pulmonary rehabilitation programme was given to them as 
the following: 
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EXERCISE SCHEDULE 
S.NO TYPE OF EXERCISE 
DURATION 
IN 
MINUTES 
NO. OF 
TIMES 
I) 
RESPIRATORY MUSCLE 
EXERCISE 
  
1. Pursed lip breathing. 2 4 
2. Diaphragmatic breathing. 2 2 
3. Deep breathing. 2 4 
II) 
MUSCLE STRENGTHENING 
EXERCISE 
  
1. Front thigh stretch. 2 2 
2. Shoulder stretch. 2 2 
3. Palm down forearm stretch. 2 2 
4. Palm up forearm stretch. 2 2 
5. Neck stretch. 2 2 
6. Leg lift. 2 4 
7. Knee lift. 2 4 
8. Knee bend. 2 4 
9. Heel lift. 2 4 
10. Leg extension 2 4 
 
Total time for all exercises including relaxation phase – 30 minutes. The topic 
was carefully chosen based on patients existing health condition. 
 (2) Second Phase 
In this present study, the second phase was the post test of the both control 
group and experimental group. It was done on 5th day. In order to consider ethical 
rights, the control group was also taught about selected pulmonary rehabilitation 
programme at the end of their post test. Both the groups are known about the 
importance of pulmonary rehabilitation at the end of the post  test. 
45 
 
The patients were then instructed to do the following: 
I. RESPIRATORY MUSCLE EXERCISE 
1) Pursed lip breathing 
 Sit upright and relax the neck and shoulder muscles. 
 Breathin normal for 2 seconds through the nose, keeping the mouth closed. 
 Breatheout for 4 seconds through pursed lips as like whistling. 
 
STEP-1               STEP-2 
 
2) Diaphragmatic exercise 
 Lie on your back on a flat surface with knees bent. Put pillows under your 
knees & head for support. 
 Place one hand on your tummy. Place the other hand on your chest. 
 Inhale deeply through the nose for a count of 3. 
 Tighten the stomach muscles and exhale for a count of 6 through slightly 
pursed lips. 
 Repeat it for 2 minutes. 
 
STEP- 1                           STEP-2 
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STEP- 3                   STEP- 4 
 
3) Deep breathing exercise 
 Sharply inhale through nose & keep your mouth closed. 
 Hold the breath for 2-3 seconds, slowly exhaling through your mouth. 
 Repeat it for 2 minutes on each nostril. 
 
 
 
STEP- 1                             STEP- 2 
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II. MUSCLE STRENGTHENING EXERCISE:- 
1) Front thigh stretch exercise 
 Stand a little way from wall and place left hand on wall for support. 
 Standing straight, grasp top of left foot with right hand. 
 Pull heel toward buttock. 
 Hold it 10 to 20 seconds. 
 Repeat the same to next thigh for 2 minutes. 
 
 
 
   
STEP- 1           STEP- 2                      STEP- 3 
 
 
 
 
 
48 
 
2) Shoulder stretch exercise 
 Sit or stand with your back straight and one hand placed on the outside of the 
elbow of the opposite arm. 
 Pull the elbow gently across the chest. 
 A stretch in the shoulder of the arm being pulled. 
 Hold it for 30 to 60 seconds. 
 Repeat 3 times on next arm for 2 minutes. 
 
 
 
  
  STEP- 1                 STEP- 2 
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3) Palm down forearm stretch exercise 
 Sit or stand with your back straight and one arm extended in front of you with 
the palm facing down. 
 Gently push down the back of the extended hand. 
 Feel a stretch in the forearm. 
 Hold it for 30-60 seconds. 
 Stretch the other palm. 
 Repeat it on next hand for 2 minutes. 
 
 
       
            STEP – 1            STEP- 2 
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4) Palm up forearm stretch exercise 
 Sit or stand with your back straight and one arm extended in front of you with 
the palm facing up. 
 With the other hand push down on the fingers of the extended hand. 
 Feel a stretch in the forearm. 
 Hold it for 30-60 seconds. 
 Stretch the next palm and repeat it for 2 minutes. 
 
 
            
 STEP-1   STEP-2           STEP-3 
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5) Neck stretch exercise 
 Sit or stand with your back straight and your feet flat on the floor. 
 Tilt your head to one side. 
 Push head with one hand and you should feel a stretch in the side of the neck 
opposite the tilt. 
 Hold it for 30-60 seconds. 
 Stretch next side and repeat it for 2 times. 
 
 
 
 
 
    
 STEP- 1        STEP- 2 & 3 
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6) Leg extension exercise 
 Sit straight. 
 Your knees forming a 90 degree angle to the floor and your hands resting 
comfortably on your knees. 
 Lean slightly forward and stand up from the chair to a straight position with 
your hands at the side of your body. 
 Hold it 10-15 seconds. 
 Return to the original position. 
 Repeat it 4 times on each legs for 2 minutes. 
 
 
             
STEP 1                                STEP- 2          STEP- 3 
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7) Leg lift exercise 
 
 Stand with your back straight resting your hands on a wall or on the back 
of a chair for balance. 
 Give one leg a small slow kick backwards. 
 Return the leg to its original position. 
 Repeat it 4 times on each legs for 2 minutes. 
 
 
 
               
        STEP- 1           STEP- 2      STEP- 3 
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8) Knee lift exercise- 
 Stand with your back straight and your hands by your sides, or stand with 
one hand on a wall or a chair for balance. 
 Lift one leg so the knee forms a 90 degree angle. 
 Return the leg to its original position. 
 Repeat it 4 times on each legs for 2 minutes. 
 
 
                              
STEP- 1                                    STEP- 2            STEP-3 
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9) Knee bend exercise 
 Stand with your back straight resting your hands on a wall or on the back of a 
chair for balance. 
 Lift your foot out behind you so your lower leg is parallel with the floor. 
 Return the foot to its original position. 
 Repeat it 4 times on each legs for 2 minutes. 
 
 
    
STEP- 1               STEP- 2                STEP- 3 
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10) Heel lift 
 Sit with your back straight, your hands resting comfortably on your knees and 
your feet felt on the floor. 
 Raise your heels. 
 Return the foot to its original position. 
 Repeat it 4 times on each legs for 2 minutes. 
 
 
 
     
      STEP 1               STEP 2                   STEP 3  
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PLAN FOR DATA ANALYSIS 
Data analysis helps the researcher to organize, summarize, evaluate, interpret 
and communicate the numerical facts. For the present study the collected data from 
the participants were grouped and analyzed using both descriptive and inferential 
statistical method. Statistical analysis was done by manually by using statistical 
formula. 
 Study plan to carry out the following analysis: 
 Gathered all the information obtained from the study. 
 Organization of data in master sheet/computer. 
 Demographic variables analyzed in terms of frequency and percentage. 
 Pre-test and post-test health well-being outcome analyzed by mean and 
standard deviation. 
 The paired ‘t’ test was used to find the difference in mean scores before and 
after selected pulmonary rehabilitation programme both within the control and 
experimental groups. 
 The unpaired ‘t’ test was used to find the difference in mean scores before and 
after selected pulmonary rehabilitation programme between the control and 
experimental groups. 
ETHICAL CONSIDERATION 
Beneficence 
The right to freedom from harm 
 Though this study is an experimental design, the interventions used were 
not of harm to the patients. 
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      The right to protection from exploitation 
 Patients information was kept confidential. 
Respect for Human Dignity 
The right to self- determination 
 Research proposal was approved by specialty HOD and other senior 
professors. 
 Ethical clearance was obtained from the ethical committee. 
 Prior permission was sought from higher authorities of institution before 
commencing the study. 
 Oral consent was formally obtained prior to collection of data from the 
participants and the confidentiality of their responses was assured. 
The right to full disclosure 
 Participants were advised of the voluntary nature of the study and given 
the option to withdraw from the study at any stage without being 
subjected to any penalty. 
 Participants were not required to identify themselves by name and have 
not been identified during the analysis or during discussion of the results 
and conclusions. 
 Full explanation of the purpose of the research was given and the 
researcher was available to provide information and support as needed,  
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Justice 
The right to fair treatment 
 Based on ethical consideration, intervention was also given to control 
group at the end of data collection procedure. 
The right to privacy 
 And they were informed data collected from questionnaire, then stored in 
computer discs for final analysis would be kept in a secure place and 
shredded after the study had been completed. 
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CHAPTER- IV 
DATA ANALYSIS AND INTERPRETATION 
 
This chapter deals with the data analysis and interpretation of the present study 
involve completion, editing, coding, classification and presentation of the data for 
statistical calculation in order to draw inferences and conclusions. Using descriptive 
and inferential statistics, the study objectives were computed. 
 The data collected from the samples were organized, analyzed and tabulated 
and interpreted to evaluate the efficacy of selected pulmonary rehabilitation 
programme on health well-being are framed based on their objectives: 
1. To assess the pre test and post test health wellbeing among patients with 
COPD in the control and experimental group. 
2. To determine the efficacy of selected pulmonary rehabilitation programme on 
health wellbeing among patients with COPD by comparing the pre test and 
post test scores within and between the control and experimental group. 
3. To associate the health wellbeing of the patients with COPD with their both 
demographic and clinical variables.  
The findings were presented in the form of tables and diagrams under the 
following series: 
Section A: Description of demographic and clinical variables among 
patients with COPD in the control and experimental group. 
1. Frequency and percentage wise distribution of samples based on their 
demographic variables in the control and experimental group. 
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2. Frequency and percentage wise distribution of samples based on their clinical 
variables in the control and experimental group. 
Section B: Description on health well-being outcome among patients with COPD 
in control and experimental group. 
1. Comparison of pre test and post test mean score of health wellbeing outcome 
of patients with COPD in control group. 
2. Comparison of pre test and post test mean score of health wellbeing outcome 
of patients with COPD in experimental group. 
3. Paired ‘t’ test showing the comparison of pre test and post test score of health 
wellbeing outcome among patients with COPD within the control group. 
4. Paired ‘t’ test showing the comparison of mean pre test and post test score of 
health wellbeing outcome among patients with COPD within the experimental 
group. 
5. Unpaired ‘t’ test showing the comparison of post test score of health wellbeing 
among patients with COPD between the control and experimental groups. 
Section C: Data on Association in the pre test level of health wellbeing among 
patients with COPD. 
1. Association between pre test health wellbeing and demographic as well as clinical 
variables among patients with COPD in the control group. 
2. Association between pre test health wellbeing and demographic as well as clinical 
variables among patients with COPD in the experimental group. 
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 FIG.4.1. Frequency and percentage wise distribution of samples based on their 
demographic variables in the control and experimental group. 
 
FIG.4.1.1 DISTRIBUTION OF PATIENTS WITH COPD ACCORDING TO 
THEIR AGE IN YEARS. 
 
 
 
Fig.4.1.1. In regard to age in years, majority of the samples 11 (36%) were 
>51 years and 13(43%) were 31- 40 years in the control and experimental group. 
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FIG.4.1.2 DISTRIBUTION OF PATIENTS WITH COPD ACCORDING TO 
THEIR GENDER. 
 
 
 
 
 
Fig.4.1.2. In regard to gender, majority of the samples 25(83%) and 25(83%) 
were males in the control and experimental group respectively. 
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FIG.4.1.3 DISTRIBUTION OF PATIENTS WITH COPD ACCORDING TO 
THEIR RELIGION. 
 
 
 
 
Fig.4.1.3. Regarding religion, among 60 samples majority of them 26(86%) 
and 26(86%) belongs to Hindu religion in the control and experimental group 
respectively. 
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FIG.4.1.4 DISTRIBUTION OF PATIENTS WITH COPD ACCORDING TO 
THEIR EDUCATIONAL STATUS. 
 
 
 
 
 
Fig.4.1.4. In regard to educational status, majority 20(67%) and 12(40%) of 
the samples were graduates in the control and experimental group respectively. 
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FIG.4.1.5 DISTRIBUTION OF PATIENTS WITH COPD ACCORDING TO 
THEIR OCCUPATION. 
 
 
 
 
Fig.4.1.5. In regard to occupational status, majority 12(40%) and 15(50%) of 
the samples were private employees in the control and experimental group 
respectively. 
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FIG.4.1.6. DISTRIBUTION OF PATIENTS WITH COPD ACCORDING TO 
THEIR INCOME. 
 
 
Fig.4.1.6. In regard to income, majority 17(57%) and 14(47%) of the samples 
were under above Rs.10000/- per month in the control and in the experimental group 
respectively. 
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FIG.4.1.7. DISTRIBUTION OF PATIENTS WITH COPD ACCORDING TO 
THEIR TYPE OF FAMILY. 
 
 
 
 
Fig.4.1.7. In regard to type of family, majority 25(83%) and 27(90%) of the 
samples were belongs to nuclear family in the control and experimental group 
respectively. 
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Figure 4.2. Frequency and percentage wise distribution of samples based on their 
clinical variables in the control and experimental group. 
FIG.4.2.1. DISTRIBUTION OF PATIENTS WITH COPD ACCORDING TO 
THEIR TYPE OF SMOKING HISTORY. 
 
 
 
 
Fig.4.2.1. In regard to smoking history, majority 13(43%) of the samples were 
“non-smoker” in the control group where as majority 16(53%) of the samples were 
the “chronic smoker” in experimental group. 
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FIG.4.2.2. DISTRIBUTION OF PATIENTS WITH COPD ACCORDING TO 
THEIR DURATION OF RESPIRATORY ILLNESS IN YEARS. 
 
 
 
 
 
Fig.4.2.2.Regarding duration of illness, majority of the samples 19(63%) and 
13(43%) were suffering between 1-3 years in the control and experimental group 
respectively. 
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FIG.4.2.3. DISTRIBUTION OF PATIENTS WITH COPD ACCORDING TO 
THEIR NUMBER OF HOSPITALIZATION DUE TO ACUTE 
EXACERBATION 
 
 
 
 
Fig.4.2.3. Regarding the number of hospitalization due to acute exacerbation, 
majority of the samples 20(67%) and 19(63%) were admitted with acute exacerbation 
for 1-3 times both in the control and experimental group respectively. 
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FIG.4.2.4. DISTRIBUTION OF PATIENTS WITH COPD ACCORDING TO 
THEIR REASON FOR ADMISSION. 
 
 
 
 
 
 
Fig.4.2.4. Regarding reason for admission, majority of the samples 13(43%) 
and 13(43%) were admitted with the complaints of dyspnea in the control and 
experimental group respectively. 
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FIG.4.2.5. DISTRIBUTION OF PATIENTS WITH COPD ACCORDING TO 
THEIR SEASON OF EXACERBATION. 
 
 
 
 
Fig.4.2.5. Regarding season of exacerbation, majority of the samples 19(63%) 
and 17(56%) were not having any specific reason for exacerbation both in the control 
and experimental group respectively. 
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FIG.4.2.6. DISTRIBUTION OF PATIENTS WITH COPD ACCORDING TO 
THEIR TRIGGERS OF EXACERBATION. 
 
 
 
 
 
Fig.4.2.6. Regarding other triggers for exacerbation, majority 12(40%) of the 
samples have triggers for air pollution and respiratory infection in the control and 
where majority 11(37%) of the samples in the experimental group have triggers for 
physical and emotional stress. 
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FIG.4.2.7. DISTRIBUTION OF PATIENTS WITH COPD ACCORDING TO 
THEIR SLEEP DISTURBANCE DUE TO. 
 
 
 
 
Fig.4.2.7. Regarding sleep disturbance, majority of the samples 13(43%) and 
12(40%) had complaints of shortness of breath in the control and experimental group 
respectively. 
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FIG.4.2.8. DISTRIBUTION OF PATIENTS WITH COPD ACCORDING TO 
THEIR COMORBIDITY. 
 
 
 
 
Fig.4.2.8. In regard to comorbidity, majority 9(34%) of the samples were 
known case of “Respiratory disease” in control group, where as majority 14(47%) of 
the samples in the experimental group were known case of “Diabetes mellitus”. 
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FIG.4.2.9. DISTRIBUTION OF PATIENTS WITH COPD ACCORDING TO 
THEIR TREATMENT MODALITIES. 
 
 
 
 
 
Fig.4.2.9. Regarding treatment modalities, majority of the samples 25(83%) 
and 24(80%) were on pulmonary medications rather than medicated inhaler in the 
control and experimental group respectively. 
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Table 4.1: Frequency and percentage wise distribution of the sample based on 
the health wellbeing within the control group. 
          (n = 30) 
Control group 
Distress 
Moderate 
wellbeing 
Positive wellbeing 
f % f % f % 
Pre test 4 13 26 87 0 0 
Post test 4 13 26 87 0 0 
 
Table 4.1: In regard to frequency and percentage wise distribution of pre- test 
and post- test score of health wellbeing in the control group. The samples were 
distributed under the category of “ Moderate wellbeing” during the pre test 26(87%)  
as well as in the post test 26 (87%), which indicates that there was no changes in the 
wellbeing level in the control group. 
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Table 4.2: Frequency and percentage wise distribution of the samples based on 
the health wellbeing within the experimental group. 
          (n = 30) 
Experimental 
group 
Distress 
Moderate 
wellbeing 
Positive wellbeing 
f % f % f % 
Pre test 2 7 28 93 0 0 
Post test 0 0 5 17 25 83 
 
Table 4.2: In regard to frequency and percentage wise distribution of pre- test 
and post- test score of health wellbeing in the experimental group, the samples were 
distributed under the category of “ Moderate wellbeing” during the pre test 28(93%) , 
whereas “Positive wellbeing” during the post test 25(83%), which  indicates that there 
was a marked improvement in the wellbeing level in the experimental group. 
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SECTION: B 
Table 4.3. Mean score difference of pre test and post test on health wellbeing 
among patients with COPD in the control group. 
(n=30) 
Health wellbeing 
Control 
group 
Max 
Score 
Mean SD Mean% Mean Difference 
Pre-test 75 44.8 8.87 59.7  
0.1 Post-test 75 44.9 8.89 59.8 
 
Table 4.3 displays the mean score difference between pre and post test health 
wellbeing in the control group. The findings show that the pre test mean score was 
(44.8 ± 8.87) and post test mean score was (44.9 ± 8.89) with the mean score 
difference of 0.1. 
This shows that there was a no significant difference between the health 
wellbeing scores of pre test and post test in the control group. 
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Table 4.4. Mean score difference of pre test and post test on health wellbeing 
among COPD patients in the experimental group. 
(n=30) 
Health wellbeing 
Experimental 
group 
Max 
Score 
Mean SD Mean% Mean Difference 
Pre-test 75 49.5 9.47 66  
20.1 Post-test 75 69.6 3.76 92.8 
 
Table 4.4 displays the mean score difference between pre and post test health 
wellbeing in the experimental group. The results show that the pre-test mean score 
was (49.5 ± 9.47) and post-test mean score was (69.6 ± 3.76) with the mean score 
difference of 20.1, infers that there was a significant difference in the experimental 
group. 
Thus, the findings were interpreted as pulmonary rehabilitation programme 
has a marked beneficiary effect on health wellbeing. 
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Table 4.5. Mean score difference in health wellbeing among patients with COPD 
between the control and experimental groups. 
(N=60) 
Health wellbeing 
Group Mean SD Mean Mean Difference % 
Control group  44.9 8.89 59.8 
24.7 Experimental 
group  
69.6 3.76 92.8 
 
Table 4.5 presents the comparison of the mean score difference between the 
control group and experimental group. In the experimental group, mean score has 
increased (69.6 ± 3.76) than the control group mean score of (44.9 ± 8.89) with the 
mean score difference of 24.7 %. 
This result signifies that there was a significant difference between the mean 
score of health wellbeing in the control group and the mean score of health wellbeing 
in the experimental group, which means that the pulmonary rehabilitation program is 
highly effective. 
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Table 4.6. Paired ‘t’ test on health wellbeing score among patients with COPD 
within the control group. 
(n=30) 
Control 
group 
Level Mean SD ‘t’ value ‘p’ value 
Pre-test 
Health well 
being 
44.8 8.87 
 
0.03 
 
0.97 
Post-test 
Health well 
being 
44.9 8.89 
 
*p<0.05 significant **p<0.01 & ***p<0.001 highly significant. 
Table 4.6 reveals that the paired ‘t’ test score on health wellbeing within the 
control group is 0.03 and P= 0.97 at p>0.05, this indicates that there was a no 
statistical significant difference between the pre test and post tests within the control 
group. 
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Table 4.7. Paired ‘t’ test on health wellbeing score among patients with COPD 
within the experimental group. 
(n=30) 
Control 
group 
Level Mean SD ‘t’ value ‘p’ value 
Pre test Health well being 49.5 9.47  
0.52 
 
0.60 Post test Health well being 69.6 3.76 
 
*p<0.05 significant **p<0.01 & ***p<0.001 highly significant. 
Table 4.7 The above mentioned, displayed that the overall ‘t’ value 0.52 and 
p>0.05, indicates that there is was a statistically significant difference between the pre 
test and post test within the experimental group. 
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Table 4.8. Unpaired ‘t’ test for comparison of health wellbeing score between 
control group and experimental group.                                                                                         
                                                                                            (N=60) 
Group Level Mean SD ‘t’ value ‘p’ value 
Control group  
Health 
well being 
44.9 8.87 
15.07 0.001*** 
Experimental 
group  
Health 
well being 
69.6 3.76 
       *p<0.05 significant **p<0.01 & ***p<0.001 highly significant. 
 
Table 4.8. elucidate the unpaired ‘t’ test score on health wellbeing between 
control and experimental group. The overall ‘t’ value 15.07 and p=0.001 at p<0.05 
which indicates that there was a marked statistical significant difference between the 
the control and the experimental group. 
  
86 
 
SECTION: C 
Table 4.9 Association between pre test health wellbeing and demographic as well 
as clinical variables among patients with COPD in control group. 
(n=30) 
S.No 
Socio demographic 
variables 
 
Distress 
Moderate 
health 
wellbeing 
Positive 
health 
wellbeing 
2 
(df) 
P- value 
(N/NS) 
f % f % f % 
1. Age in years 
a) 21-30 
b) 31-40 
c) 41-50 
d) >51 
 
0 
2 
2 
0 
 
0 
7 
7 
0 
 
2 
5 
8 
11 
 
7 
17 
27 
36 
 
0 
0 
0 
0 
 
0 
0 
0 
0 
1.78 
(df=6) 
0.93 
NS 
2. Gender 
a) Male 
b) Female 
 
4 
0 
 
13 
0 
 
21 
5 
 
70 
17 
 
0 
0 
 
0 
0 
 
0.06 
(df=2) 
 
0.97 
NS 
3. Religion 
a) Hindu 
b) Muslim 
c) Christian 
 
4 
0 
0 
 
13 
0 
0 
 
22 
2 
2 
 
73 
7 
7 
 
0 
0 
0 
 
0 
0 
0 
 
0.06 
(df=4) 
 
0.99 
NS 
4. Educational status 
a) Primary school 
b) High school 
c) Graduate 
d) Illiterate 
 
0 
1 
3 
0 
 
0 
3 
10 
0 
 
4 
2 
17 
3 
 
13 
7 
57 
10 
 
0 
0 
0 
0 
 
0 
0 
0 
0 
 
2.42 
(df=6) 
 
0.87 
NS 
5. Occupation 
a) Coolie 
b) Private 
employee 
c) Government 
employee 
d) Housewife 
e) Retired 
 
0 
4 
 
0 
 
0 
0 
 
0 
13 
 
0 
 
0 
0 
 
3 
8 
 
10 
 
1 
4 
 
10 
27 
 
33 
 
3 
13 
 
0 
0 
 
0 
 
0 
0 
 
0 
0 
 
0 
 
0 
0 
 
2.38 
(df=8) 
 
0.96 
NS 
6. Income 
a) Below Rs.5000 
b) Rs.5000-10000 
c) Above Rs.10000 
 
0 
1 
3 
 
0 
3 
10 
 
6 
6 
14 
 
20 
20 
47 
 
0 
0 
0 
 
0 
0 
0 
0.12 
(df=4) 
0.99 
NS 
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7. Type of family 
a) Joint family 
b) Nuclear family 
 
0 
4 
 
 
0 
13 
 
 
5 
21 
 
 
17 
70 
 
 
0 
0 
 
 
0 
0 
 
 
0.06 
(df=2) 
 
0.97 
NS 
8. Smoking history 
a) Non-smoker 
b) Ex- smoker 
c) Occasional 
smoker 
d) Chronic smoker 
 
4 
0 
0 
 
0 
 
13 
0 
0 
 
0 
 
9 
4 
9 
 
4 
 
30 
13 
30 
 
13 
 
0 
0 
0 
 
0 
 
0 
0 
0 
 
0 
 
1.81 
(df=6) 
 
0.93 
NS 
9. Duration of 
respiratory illness in 
years 
a) 1-3 years 
b) 4-6 years 
c) 7-9 years 
d) >10 years 
 
 
 
3 
1 
0 
0 
 
 
 
10 
3 
0 
0 
 
 
 
16 
7 
3 
0 
 
 
 
53 
23 
10 
0 
 
 
 
0 
0 
0 
0 
 
 
 
0 
0 
0 
0 
 
 
0.05 
(df=6) 
 
 
1.00 
NS 
10. Number of 
hospitalization due to 
acute exacerbation 
a) 1-3 times 
b) 4-6 times 
c) 7-9 times 
d) >10 times 
 
 
 
2 
1 
0 
1 
 
 
 
7 
3 
0 
3 
 
 
 
18 
6 
2 
0 
 
 
 
60 
20 
7 
0 
 
 
 
0 
0 
0 
0 
 
 
 
0 
0 
0 
0 
 
 
5.90 
(df=6) 
 
 
0.43 
NS 
11. Reason for admission 
a) Chronic cough 
b) Chronic wheeze 
c) Dyspnea 
d) All the above 
1 
0 
3 
0 
3 
0 
10 
0 
3 
7 
10 
6 
10 
23 
33 
20 
0 
0 
0 
0 
0 
0 
0 
0 
 
1.36 
(df=6) 
 
0.96 
NS 
12. Season of 
exacerbation 
a) Rainy season 
b) Winter season 
c) Summer season 
d) Not specific 
 
 
1 
3 
0 
0 
 
 
3 
10 
0 
0 
 
 
4 
3 
0 
19 
 
 
13 
10 
0 
63 
 
 
0 
0 
0 
0 
 
 
0 
0 
0 
0 
 
 
8.01 
(df=6) 
 
 
0.23 
NS 
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13. 
Triggers for 
exacerbation 
a) Physical and 
emotional stress 
b) Biomedical fuel 
c) Air pollution 
d) Respiratory 
infection 
 
0 
 
0 
3 
1 
 
0 
 
0 
10 
3 
 
5 
 
1 
9 
11 
 
17 
 
3 
30 
37 
 
0 
 
0 
0 
0 
 
0 
 
0 
0 
0 
0.94 
(df=6) 
0.98 
NS 
14. Sleep disturbance 
a) Chronic cough 
b) Shortness of 
breath 
c) Chest pain 
d) Others 
 
0 
1 
 
0 
3 
 
0 
3 
 
0 
10 
 
6 
12 
 
4 
4 
 
20 
40 
 
13 
13 
 
0 
0 
 
0 
0 
 
0 
0 
 
0 
0 
5.26 
(df=6) 
0.51 
NS 
15. Comorbidity 
a) Cardiovascular 
disease 
b) Diabetes mellitus 
c) Respiratory 
disease 
d) Others 
 
1 
 
1 
2 
 
0 
 
3 
 
3 
7 
 
0 
 
7 
 
8 
8 
 
3 
 
23 
 
27 
27 
 
10 
 
0 
 
0 
0 
 
0 
 
0 
 
0 
0 
 
0 
0.30 
(df=6) 
0.99 
NS 
16. Treatment modalities 
a) Pulmonary 
medication 
b) Medicated inhaler 
 
4 
 
0 
 
13 
 
0 
 
21 
 
5 
 
70 
 
17 
 
0 
 
0 
 
0 
 
0 
0.06 
(df=2) 
0.97 
NS 
S - Significant, NS – Not significant 
 
Table 4.9.revealed that there was an insignificant association exist between 
demographic as well as clinical variables, with chi- square value 0.06 (p>0.05). 
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Table 4.10. Association between pre test health well-being and demographic as 
well as clinical variables among patients with COPD in the experimental group. 
          (n=30) 
S.No 
 
Socio demographic 
variables 
Distress 
Moderate 
health 
wellbeing 
Positive 
health 
wellbeing 
2 
(df) 
P- 
value 
(N/N
S) f % f % f % 
1. Age in years 
a) 21-30 
b) 31-40 
c) 41-50 
d) >51 
 
0 
0 
0 
0 
 
0 
0 
0 
0 
 
0 
3 
0 
2 
 
0 
10 
0 
7 
 
2 
10 
7 
6 
 
7 
33 
23 
20 
 
0.38 
(df=6) 
 
0.99 
NS 
2. Gender 
a) Male 
b) Female 
 
0 
0 
 
0 
0 
 
5 
0 
 
17 
0 
 
20 
5 
 
67 
17 
 
0.08 
(df=2) 
 
0.96 
NS 
3. Religion 
a) Hindu 
b) Muslim 
c) Christian 
 
0 
0 
0 
 
0 
0 
0 
 
3 
2 
0 
 
10 
7 
0 
 
23 
2 
0 
 
77 
7 
0 
 
1.01 
(df=4) 
 
0.90 
NS 
6. Income 
a) Below Rs.5000 
b) Rs.5000-10000 
c) Above Rs.10000 
 
0 
0 
0 
 
0 
0 
0 
 
1 
3 
1 
 
3 
10 
3 
 
5 
7 
13 
 
17 
23 
43 
0.95 
(df=4) 
0.91 
NS 
7. Type of family 
a) Joint family 
b) Nuclear family 
 
0 
0 
 
0 
0 
 
2 
3 
 
7 
10 
 
1 
24 
 
3 
80 
 
9.47 
(df=2) 
 
0.008 
S 
8. Smoking history 
a) Non-smoker 
b) Ex- smoker 
c) Occasional smoker 
d) Chronic smoker 
 
0 
0 
0 
0 
 
0 
0 
0 
0 
 
0 
1 
1 
3 
 
0 
3 
3 
10 
 
4 
2 
6 
13 
 
13 
7 
20 
43 
1.1 
(df=6) 
0.98 
NS 
90 
 
9. Duration of respiratory 
illness in years 
a) 1-3 years 
b) 4-6 years 
c) 7-9 years 
d) >10 years 
 
 
0 
0 
0 
0 
 
 
0 
0 
0 
0 
 
 
3 
1 
1 
0 
 
 
10 
3 
3 
0 
 
 
10 
10 
4 
1 
 
 
33 
33 
13 
3 
 
 
 
0.43 
(df=6) 
 
 
 
0.99 
NS 
10. Number of hospitalization 
due to acute exacerbation 
a) 1-3 times 
b) 4-6 times 
c) 7-9 times 
d) >10 times 
 
 
0 
0 
0 
0 
 
 
0 
0 
0 
0 
 
 
3 
1 
1 
0 
 
 
10 
3 
3 
0 
 
 
16 
4 
2 
1 
 
 
53 
13 
7 
3 
 
 
3.02 
(df=6) 
 
 
0.80 
NS 
11. Reason for admission 
a) Chronic cough 
b) Chronic wheeze 
c) Dyspnea 
d) All the above 
 
0 
0 
0 
0 
 
0 
0 
0 
0 
 
0 
1 
3 
1 
 
0 
3 
10 
3 
 
4 
6 
10 
5 
 
13 
20 
33 
17 
0.19 
(df=6) 
0.99 
NS 
12. Season of exacerbation 
a) Rainy season 
b) Winter season 
c) Summer season 
d) Not specific 
 
0 
0 
0 
0 
 
0 
0 
0 
0 
 
1 
3 
0 
1 
 
3 
10 
0 
3 
 
5 
4 
0 
16 
 
17 
13 
0 
53 
3.12 
(df=6) 
0.79 
NS 
13. Triggers for exacerbation 
a) Physical and emotional 
stress 
b) Biomedical fuel 
c) Air pollution 
d) Respiratory infection 
 
0 
 
0 
0 
0 
 
0 
 
0 
0 
0 
 
3 
 
0 
1 
1 
 
10 
 
0 
3 
3 
 
8 
 
1 
8 
8 
 
20 
 
3 
20 
20 
 
4.9 
(df=6) 
 
0.55 
NS 
14. Sleep disturbance 
a) Chronic cough 
b) Shortness of breath 
c) Chest pain 
d) Others 
 
0 
0 
0 
0 
 
0 
0 
0 
0 
 
1 
2 
1 
1 
 
3 
7 
3 
3 
 
7 
10 
5 
3 
 
23 
33 
17 
10 
 
0.45 
(df=6) 
 
0.99 
NS 
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15. Comorbidity 
a) Cardiovascular disease 
b) Diabetes mellitus 
c) Respiratory disease 
d) Others 
 
0 
0 
0 
0 
 
0 
0 
0 
0 
 
1 
2 
2 
0 
 
3 
7 
7 
0 
 
9 
12 
4 
0 
 
30 
40 
13 
0 
 
 
1.48 
(df=6) 
 
 
0.96 
NS 
16. Treatment modalities 
a) Pulmonary medication 
b) Medicated inhaler 
 
0 
0 
 
0 
0 
 
3 
2 
 
10 
7 
 
21 
4 
 
70 
13 
 
1.5 
(df=2) 
 
0.47 
NS 
 
S - Significant, NS – Not significant 
 
Table 4.10. presents that there was an statically insignificant association exist 
between the demographic as well as clinical variable except type of family, with chi- 
square value 9.47 (p<0.05).  
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CHAPTER- V 
DISCUSSION 
The present study was conducted to evaluate the efficacy of selected 
pulmonary rehabilitation programme on health wellbeing level among patients with 
COPD at Vadamalayan Hospital in Madurai. After the analysis and interpretation of 
the data obtained from the samples, the researcher found, there was a significant 
increase on health wellbeing among patients with COPD. 
The discussion was fully based on the objectives and hypotheses specified in 
this present study. 
The discussion is based on the objectives and Hypothesis specified in this study. 
Objectives of the study were  
1. To assess the pre test and post test health wellbeing among patients with 
COPD in the control and experimental group. 
2. To determine the efficacy of pulmonary rehabilitation programme on health 
wellbeing among patients with COPD by comparing the pre test and post test 
scores within and between the control and experimental group. 
3. To associate the health wellbeing of the patients with COPD with their 
demographic and clinical variables.  
Hypothesis of the study were to 
H1- There is a significant difference in the pre test and post test scores of 
health wellbeing among patients with COPD in the control and experimental group. 
H2- The mean post test score of health wellbeing is significantly higher in the 
patients with COPD who were exposed to selected pulmonary rehabilitation 
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programme than the patients those who were not exposed to selected pulmonary 
rehabilitation programme. 
H3- There is a statistical significant association between health wellbeing with 
their demographic and clinical variables in the both control and experimental group. 
The first objective of this study was to assess the pre test and post test health 
wellbeing among patients with COPD in the control and experimental group. 
The above objective of the study was to identify the level of health well-being 
regarding selected pulmonary rehabilitation programme among patients with COPD 
before and after implementation of the live demonstration and flash card programme. 
Regarding pre test level of health well-being  in the control group revealed 
most of the patients had distressed 4(13%)  in both  pre test and post test. 26(87%) 
patients had moderate wellbeing in both pre test and post test. It was noted that no one 
had positive wellbeing in both pre test and post test. 
In the experimental group, 2(7%) had distress and 28(93%) had moderate 
well-being in the pre test, whereas in the post test majority 25(83%) had positive 
wellbeing and 5(17%) had moderate wellbeing. Hence, it is clearly judged that the 
health wellbeing has improved to in the experimental group after implementing 
pulmonary rehabilitation programme among patients with COPD. 
The present study was supported by Puhan MA et al., (2016), middle east 
countries on pulmonary rehabilitation following exacerbations of COPD patients. The 
finding shows that high-quality evidence suggests that pulmonary rehabilitation after 
an exacerbation improves health-related quality of life. St George’s Respiratory 
Questionnaire (SGRQ) reported a statistically significant effect on SCRQ total score, 
which was above the minimal important difference (MID) of four points (mean 
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difference (MD) -7.80, 95% CL-12.212 to -3.47: I² = 64%. Investigators also noted 
statistically significant and important effects (greater than MID) for the impact and 
activities domain of the SGRQ. High- quality evidence shows that six-minute walk 
distance improved, on average, by 62 meters (95% CI 38 to 86: I² = 87%). Hence, the 
findings shows that high- quality evidence suggests that pulmonary rehabilitation after 
an exacerbation improves health-related quality of life. 
Thus, the study reveals that there was a statistical significant association 
between the health wellbeing scores in both control and experimental group. Hence 
the research hypothesis (H1) was accepted. 
The second objective of the study was to determine the efficacy of pulmonary 
rehabilitation programme on health wellbeing among patients with COPD by 
comparing the pre test and post test scores within and between the control and 
experimental group. 
 In the control group, the mean pre test wellbeing score was (44.8 ± 8.87) and 
the mean post test wellbeing score was (44.9 ± 8.89), with a mean difference of 0.1. 
In the experimental group, the mean pre test wellbeing score was (49.5 ± 9.47) 
and the mean post test wellbeing score was (69.6 ± 3.76), with a mean difference                   
of 20.1. 
The mean post test well-being score (69.6 ± 3.76) in the experimental group 
was found to be significantly higher than the post test wellbeing score (44.9 ± 8.89) in 
the control group, with the mean difference of 24.7. It shows that the pulmonary 
rehabilitation programme among COPD patients was effective in the experimental 
group. 
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Regarding health wellbeing obtained from ‘t’ test value on the control group 
and experimental group after the pulmonary rehabilitation programme on health 
wellbeing among COPD patients was 15.07 (p>0.001). It indicates that the wellbeing 
of COPD patients was improved after the implementation on the pulmonary 
rehabilitation programme in experimental group. 
Regarding health well-being, obtained paired ‘t’ test value of experimental 
group was 0.52 at p>0.05 level, which indicates this difference is considered to be 
highly significant and paired ‘t’ test value of the control group was 0.03 at p<0.001, 
which shows no significance. 
The study was supported by Garrod R et al., (2004) in United Kingdom a 
retrospective study to assess the effectiveness of pulmonary rehabilitation among 
COPD patients. Baseline measures consisted of activity of daily living, mood state, 
spirometry, exercise tolerance using the Incremental Shuttle Walk Test (ISWT) and 
health status using the St George Hospital Respiratory Questionnarie (SGRQ). 
Responder analysis showed that 37%of patients achieved benefits for both the SGRQ 
and the ISWT. 28% of patients were non-responders for both; 17% benefited for the 
SGRQ only and 14% improved their exercise tolerance. The paired ‘t’ test score on 
health well-being outcome within the experimental group. The paired ‘t’ test value 
was 0.52, that was greater  than P value (P<0.05), which shows that there is a 
significant difference between the pre test and post test score which shows there is a  
significant difference in the pre test and post test score in experimental group. 
The unpaired ‘t’ test score on health well-being outcome between control and 
experimental group. The findings show that the overall pre-test score was 15.07, the 
corresponding P value was 0.001. The P value was less than ‘t’ value, which shows 
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there is significant difference between the pre test scores in control and experimental 
group mean scores. 
Thus, the study results shows that there is a statistical significant difference 
between the pre test and post test scores both in the control and experimental group. 
Hence the research hypothesis (H2) was accepted. 
The third objective was to associate the health wellbeing of the patients with 
COPD by their demographic and clinical variables in the both control and 
experimental group.  
The findings of the study revealed that there was an statically insignificant 
association exist between the demographic as well as clinical variable except type of 
family, with chi- square value 9.47 (p<0.05).  
This study was supported by Renata Claudia Zanchet et.al, (2005)., in middle 
east countries, Conducted a study on efficacy of pulmonary rehabilitation exercise 
capacity, respiratory muscle strength and quality of life in patients with chronic 
obstructive pulmonary disease. Results shows that Mean age was 65 ± 5 years, mean 
body mass index was 25 ± 4 kg/m2, mean forced expiratory volume in one second was 
55 ± 25% of predicted, mean ratio between forced expiratory volume in one second 
and forced vital capacity was 50 ± 12%, and mean arterial oxygen tension was 70 ± 7 
mmHg. Comparison of pre- and post-pulmonary rehabilitation values revealed 
improvement in the distance walked in the 6-minute walk test (513 ± 99 m vs. 570 ± 
104 m), maximum upper limb load (2 ± 1 kg vs. 3 ± 1 kg) and maximal inspiratory 
pressure (-89 ± 23 cmH2O vs. -102 ± 23 cmH2O), as well as in the activity domain, 
impact domain and total score on the Saint George's Respiratory Questionnaire. 
Hence the research hypothesis (H3) was not accepted. 
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CHAPTER - VI 
SUMMARY AND RECOMMENDATIONS 
A study is to be incomplete, if its results are not communicated effectively to 
its users and consumers. This chapter deals with the summary and conclusion drawn. 
It focus on the implications and gives recommendation for Nursing education, 
Nursing practice, Nursing administration and Nursing research. 
SUMMARY OF THE STUDY 
The main focus of the present study was to evaluate the efficacy of pulmonary 
rehabilitation programme on health wellbeing among patients with COPD at selected 
hospitals in Madurai. 
The design adopted for the study was “Quasi experimental pre-test post-test 
control group” in nature and the conceptual framework was based on Modified J.W 
Kenny’s open system model, 1999. The study tool contains the demographical, 
clinical variable data of the samples and modified health well-being scale. 
The main study was conducted at Vadamalayan Hospital in Madurai and a 
sample of 60 patients were selected based on the inclusion criteria, in which 30 
patients were allotted to the experimental group and the remaining 30 patients were in 
the control group. The sampling technique used was non-probability convenient 
sampling technique and the data were collected after get consent from the patients. 
The data collection procedure took a period of 6 weeks. 
Analysis was done using descriptive and inferential statistics, the obtained 
results were presented using tables and figures. 
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The objectives of the study findings were as follows 
1. To assess the pre test and post test health wellbeing among patients with 
COPD in the control and experimental group. 
2. To determine the efficacy of selected pulmonary rehabilitation programme on 
health wellbeing among patients with COPD by comparing the pre test and 
post test scores within and between the control and experimental group. 
3. To associate the health wellbeing of the patients with COPD by their 
demographic and clinical variables.  
The research Hypothesis stated were, 
H1- There is a significant difference in the pre test and post test scores of 
health wellbeing among patients with COPD in the control and experimental group. 
H2- The mean post test score of health wellbeing is significantly higher in the 
patients with COPD who were exposed to selected pulmonary rehabilitation 
programme than the patients those who were not exposed to selected pulmonary 
rehabilitation programme. 
H3- There is a statistical significant association between health wellbeing with 
the demographic and clinical variables in the both control and experimental group. 
MAJOR FINDINGS OF THE STUDY 
 The efficacy of selected pulmonary rehabilitation programme in the 
experimental group was significantly higher after the intervention. 
 Level of health wellbeing score is improved after selected pulmonary 
rehabilitation programme. 
 Paired overall “t” value in experimental group 0.52 and p value 0.60 was 
highly significant. 
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 Unpaired overall “t” value in pre test between control and experimental group 
15.07 and p value 0.001 was highly significant. 
 There was a no significant association between the pre test on selected 
pulmonary rehabilitation programme among patients with COPD in control 
group with their selected demographical. 
 There was a no significant association between the pre test on selected 
pulmonary rehabilitation programme among patients with COPD in 
experimental group with their selected demographical. 
LIMITATIONS 
1. This study is limited to assess only health wellbeing among patients with 
COPD. 
2. The samples size was only 60. 
3. Data collection procedure was done for 6 weeks only.  
NURSING IMPLICATIONS 
The results obtained from the present study proclaimed that, use of selected 
pulmonary rehabilitation programme will reduce complaints and improve health 
wellbeing status in adult patients. The study also recommended the following 
implications in the nursing professional areas such as, 
 Nursing practice 
 Nursing education 
 Nursing administration 
 Nursing research 
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Nursing Practice 
1. These findings will help the nurses in clinical sector to implement the use of 
selected pulmonary rehabilitation programme on COPD patient in medical 
ward. 
2. The method of using selected pulmonary rehabilitation programme will be 
helpful in reducing the complaints and improve the health wellbeing of the 
patient. 
3. This method of selected pulmonary rehabilitation programme will enhance 
comfort to the patient. 
4. This method will improve the health seeking behavior of patients in future. 
5. It helps to improve the standard of providing nursing care by implementing 
evidence based practice. 
Nursing Education 
1. This study finding pushes the nursing curriculum to provide opportunities for 
students to learn more pulmonary rehabilitation programme.  
2. This study promotes nursing specialization in pulmonary rehabilitation 
programme. 
3. This study gives an opportunity for nursing professionals to educate the 
patients with COPD. 
Nursing Administration 
1. The study findings help the nurse administrator in formulating revised 
protocols and policies on pulmonary rehabilitation programme. 
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2. The findings of the study provides opportunity for the nurse administrators to 
conduct in service education regarding evidence based nursing practice on 
rehabilitation programme. 
3. Nursing administrators should give opportunity for nursing staff to create 
interest and enhanced ability in educating the patients with COPD regarding 
pulmonary rehabilitation programme. 
4. Nursing administrators should take part in health policy making, developing 
protocols and standing order related to rehabilitation programme. 
Nursing Research 
1. Nursing theories must be formulated regarding selected pulmonary 
rehabilitation programme based on the new evolving research. 
2. This study helps the nurse researcher to develop insight about the teaching 
module and materials for patients with COPD towards promotion on 
pulmonary rehabilitation programme and improving their health wellbeing. 
3. This study can published in journals to disseminate knowledge regarding 
benefits on pulmonary rehabilitation programme to improve health wellbeing 
level among patients with COPD. 
CONCLUSION 
The main conclusion of this study, shows that there was a significant 
improvement health wellbeing among patients with COPD after selected pulmonary 
rehabilitation programme. It can be concluded that selected pulmonary rehabilitation 
programme is an effective and economical method for improving the physical activity 
capacity and health wellbeing of patients with COPD. The investigator assures that 
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every patient who has been taking part in this study will have improved health 
wellbeing level. 
RECOMMENDATION 
On the basis of the findings of this study, the following recommendation has 
been made for further studies. 
 A similar study can be undertaken with larger number of samples. 
 A similar study can be conducted in other settings. 
 A longer period of intervention can be studied for more effectiveness. 
 A similar study needs to be conducted in other private and government 
hospitals in order to draw a generalization. 
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APPENDIX – A 
 
LETTER FOR SEEKING EXPERTS OPINION FOR CONTENT 
VALIDITY 
From 
E. Prasanna Kumar, 
II M. Sc Nursing Student, 
C. S. I. Jeyaraj Annapackiam College of Nursing, 
Madurai- 625004. 
To 
Respected Sir/ Madam, 
Sub:  Requisition for opinion and suggestion of experts for establishing content 
validity of research tool-reg. 
 
With due regards, I kindly bring to your notice that I am a post graduate 
student of the C. S. I Jeyaraj Annapackiam College of Nursing, Madurai. I selected 
the below mentioned topic for dissertation to be submitted to the Tamil Nadu                
Dr. M. G. R. Medical University, Chennai, as a part of partial fulfillment for the 
Master of Science in Nursing. 
“A study to evaluate the efficacy of selected pulmonary rehabilitation 
programme on health wellbeing among patients with COPD at selected hospitals 
in Madurai”. 
I am in need of your valuable opinions and suggestions regarding the tool 
which I have prepared. So I humbly request you to spare a little of your precious time 
to validate the tool, for which I will remain ever grateful to you. 
Thanking you in anticipation, 
 
Place: Madurai.                                                                       Yours sincerely, 
Date:                                                               (E.PRASANNA KUMAR) 
 
 
108 
 
APPENDIX-B 
LETTER SEEKING PERMISSION TO CONDUCT PILOT STUDY 
From 
E. Prasanna Kumar, 
II M. Sc Nursing Student, 
C. S. I. Jeyaraj Annapackiam College of Nursing, 
Madurai- 625004. 
To 
 
Forwarded through, 
 The Principal, 
 Prof .Dr. C. Jothi Sophia, M.Sc. (N).Ph.D. (N) , 
 C.S.I. Jeyaraj Annapackiam College of Nursing, 
Pasumalai, 
Madurai-4. 
Respected Sir/Madam, 
Sub: seeking permission to conduct the pilot study. 
 With due regards, I kindly bring you to your notice that, I am doing my post- 
graduation in nursing at C.S.I. Jeyaraj Annapackiam College of Nursing, Pasumalai, 
Madurai. I have selected the below mentioned topic for dissertation to be submitted to 
The Tamil Nadu Dr. M.G.R. Medical University, Chennai as a partial fulfillment of 
Master of Science in Nursing. 
 “A study to evaluate the efficacy of selected pulmonary 
rehabilitation programme on health wellbeing among patients with COPD at 
selected hospitals in Madurai”. 
 I have planned to do my pilot study in your esteemed institution. So I humbly 
request you to give me permission to conduct the study for which I remain grateful. 
Thanking you 
 
Place: Madurai.                                                                            Yours sincerely, 
Date:                                                               (E.PRASANNA KUMAR) 
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APPENDIX-C 
LETTER SEEKING PERMISSION TO CONDUCT RESEARCH STUDY 
From 
E. Prasanna Kumar, 
II M. Sc Nursing Student, 
C. S. I. Jeyaraj Annapackiam College of Nursing, 
Madurai- 625004. 
To 
 
Forwarded through, 
 The Principal, 
 Prof .Dr. C. Jothi Sophia, M.Sc. (N).Ph.D. (N), 
 C.S.I. Jeyaraj Annapackiam College of Nursing, 
Pasumalai, 
Madurai-4. 
Respected Sir/Madam, 
Sub: seeking permission to conduct the pilot study. 
 With due regards, I kindly bring you to your notice that, I am doing my post- 
graduation in nursing at C.S.I. Jeyaraj Annapackiam College of Nursing, Pasumalai, 
Madurai. I have selected the below mentioned topic for dissertation to be submitted to 
The Tamil Nadu Dr. M.G.R. Medical University, Chennai as a partial fulfillment of 
Master of Science in Nursing. 
 “A study to evaluate the efficacy of selected pulmonary rehabilitation 
programme on health wellbeing among patients with COPD at Vadamalayan 
Hospital in Madurai”. 
 I have planned to do my research study in your esteemed institution. So I 
humbly request you to give me permission to conduct the study for which I remain 
grateful. 
Thanking you 
 
Place: Madurai.                                                                            Yours sincerely, 
Date:                                                               (E.PRASANNA KUMAR) 
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APPENDIX-D 
CERTIFICATE OF VALIDATION 
 
This is to certify that the tool developed by Mr. E. Prasanna Kumar final 
year M. Sc Nursing student of C. S. I. Jeyaraj Annapackiam College Of Nursing, 
Madurai (affiliated to the Tamil Nadu Dr. M. G. R. Medical University) is validated 
by the undersigned and he can proceed with this tool and conduct the main study for 
dissertation entitled “A study to evaluate the efficacy of selected pulmonary 
rehabilitation programme on health wellbeing among patients with COPD at 
selected hospitals in Madurai”. 
 
Place: 
Signature 
Date: 
Name: 
Designation: 
Address: 
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APPENDIX-E 
LIST OF EXPERTS 
1. Dr. A. Charles Stephen Rajasing, M.S., M.C.H.,  
Medical Director, 
Christian Mission Hospital, 
Madurai-1. 
2. Dr. A. Sivaraj, M.B.B.S., D.M.R.T., F.C.I.P., 
Medical Director, 
Kavitha Hospital, 
Vellore. 
3.  Prof. Dr. Jaya Thanga Selvi, M. Sc (N) , Ph.D., 
HOD of Medical - Surgical Nursing Dept,  
C.S.I Jeyaraj Annapackiam College of Nursing,  
Madurai. 
4.  Prof. Dr. Priscilla, M.Sc (N), Ph.D.,  
Professor, Medical - Surgical Nursing Dept,  
C.S.I Jeyaraj Annapackiam College of Nursing,  
Madurai. 
5. Mrs. Anbu Roseline, M.Sc (N), 
Associate Professor, Medical – Surgical Nursing Dept, 
Sivakasi Medical Hospital School of Nursing, 
Sivakasi. 
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6. Mrs. Jeyajothi, M. Sc (N), 
Associate Professor, Medical – Surgical Nursing Dept, 
C.S.I Jeyaraj Annapackiam College of Nursing,  
Madurai. 
7. Mrs. Sasikala,  M. Sc (N), 
Lecture, Medical – Surgical Nursing Dept, 
C.S.I Jeyaraj Annapackiam College of Nursing,  
Madurai. 
8. Mr. Geopaul Rufus,  M. Sc (N), 
Lecture, Medical – Surgical Nursing Dept, 
Bishop College of Nursing, 
Pudukottai. 
9. Mr. Albert Blesson, M. Sc (N), 
Lecture, Medical – Surgical Nursing Dept, 
Mount Zion College of Nursing, 
Pudukottai. 
10. Mr. Mani, M.Sc (N)., M. Phil., 
Bio- Statistician, 
Meenakshi Mission hospital, 
Madurai. 
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APPENDIX – F 
 
PART- I 
SECTION- A 
DEMOGRAPHIC VARIABLES 
INSTRUCTIONS: 
Please put a tick () mark in the following options. I assure that your answers 
and responses will be kept confidentially.  
1) Age in years. 
a) 21- 30 years. 
b) 31-40 years. 
c) 41- 50 years. 
d) > 50 years. 
2) Gender. 
a) Male. 
b) Female. 
3) Religion. 
a) Hindu. 
b) Muslim. 
c) Christian. 
4) Educational status. 
a) Primary school. 
b) High school. 
c) Graduate. 
d) Illiterate. 
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5) Occupation. 
a) Coolie. 
b) Private employee. 
c) Government employee. 
d) Housewife. 
e) Retired. 
6) Income. 
a) Below 5000/ Month 
b) 5000- 10000/ Month 
c) Above 10000/ Month 
7) Type of family. 
a) Joint family. 
b) Nuclear family. 
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SECTION- B 
CLINICAL VARIABLES 
1) Smoking history. 
a) Nonsmokers. 
b) Ex- smokers. 
c) Occasional smokers. 
d) Chronic smokers. 
2) Duration of respiratory illness in years. 
a) 1- 3 years. 
b) 4-6 years. 
c) 7-9 years. 
d) >10 years. 
3) Number of previous hospitalization due to acute exacerbation of COPD.   
a) 1-3 times. 
b) 4-6 times. 
c) 7-9 times. 
d) >10 times. 
4) Reason for admission. 
a) Chronic cough. 
b) Chronic wheeze. 
c) Dyspnea. 
d) All the above. 
5) Season of exacerbation. 
a) Rainy season. 
b) Winter season. 
c) Summer season. 
d) Not specific. 
6) Other triggers for exacerbation. 
a) Physical and emotional stress. 
b) Biomedical fuel. 
c) Air pollution. 
d) Respiratory infection. 
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7) Sleep disturbance due to. 
a) Chronic cough. 
b) Shortness of breath. 
c) Chest pain. 
d) Others. 
8) Comorbidity. 
a) Cardiovascular diseases. 
b) Diabetes mellitus. 
c) Respiratory diseases. 
d) Others. 
9) Treatment modalities. 
a) Pulmonary medication. 
b) Medicated inhaler. 
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PART- 2 
MODIFIED HEALTH WELLBEING SCALE. 
INSTRUCTION: 
Put a tick () mark on the appropriate answer for the following modified                    
wellbeing statements. 
PHYSIOLOGICAL WELLBEING 
1- Not at all, 2- Some times, 3- All the time 
PHYSICAL, EMOTIONAL, SOCIAL & SPRITUAL WELLBEING 
   1- Much difficulty, 2- Some difficulty, 3- No difficulty 
S.NO. CRITERIA 1 2 3 
I) PHYSIOLOGICAL WELLBEING Not at all 
Some 
times 
All the 
time 
1. Cough crisis during the day/ all the 
time. 
   
2. Having phlegm in the chest.    
3. Feeling of chest tightness.    
4. Unable to sleep soundly.    
5. Shortness of breath due to any reason.    
6. Wheezing.    
7. Acute exacerbation due to any reason.    
8. Feeling of exhaustion.     
9. Difficult in waking up in the morning.    
10. Feeling of fatigue.    
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II) PHYSICAL WELLBEING 
1    
 Much 
difficulty 
2     
Some 
difficulty 
3        
 No 
difficulty 
11. Unable to do daily activity of life.    
12. Problems with doing hobbies.    
13. Feeling of unhealthy.    
14. Able to sleep soundly.    
15. Poor appetite.    
III) EMOTIONAL WELLBEING    
16. Feel dependent upon others.    
17. Difficult to relax.    
18. Not felt worthwhile.    
19. Felt sad and depressed.    
IV) SOCIAL WELLBEING:    
20. Poor support from the family.    
21. Financial difficulties.    
22. Difficult to look after the family.    
23. Feeling of low self-esteem.    
V) SPRITUAL WELLBEING:    
24. Religious events are not important to 
life. 
   
25. Unable to concentrate on religious 
activities. 
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பகுதி 1 
பிரிவு – அ 
 
மக்கள்ததொகக மொறிகள் 
அறிமுகம்:- 
தயவு தெய்து பின்வரும் ெரியொன விருப்பங்களில் ()  குறி கவக்கவும். 
உங்கள் பதில்கள் மற்றும் மறுதமொழிகள் இரகெியமொக கவக்கப்படும் 
என்று நொன் உறுதியளிக்கிறறன். 
  
1) வயது 
அ ) 21-30 
ஆ) 31-40 
இ) 41-50 
ஈ)  >50 
2) பொலினம் 
அ ) ஆண் 
ஆ) தபண் 
3) மதம் 
அ) இந்து 
ஆ) இஸ்லொமியர் 
இ) கிறித்துவர் 
4) கல்விதகுதி 
அ) ஆரொம்புகல்வி 
ஆ) உயர்கல்வி 
இ) பட்டதொரி 
ஈ) படிக்கொதவர் 
5) பணி 
அ)  கூலி 
ஆ) தனியொர்ஊழியர் 
இ)  அரசுஊழியர் 
ஈ)  இல்லத்தரெி 
உ)  பணிநிகறவுறபொற்றவர் 
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6) வருமொனம் 
அ) 5000 க்குகீழ் 
ஆ) 5000-10000 
இ)  10000க்குறமல் 
7) குடும்பசூழல் 
அ) கூட்டுகுடும்பம் 
ஆ)தனிகுடும்பம் 
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பிரிவு – ஆ 
மருத்துவமொறிகள் 
1 புககபிடிக்கும் பழக்கம் 
அ) புகக பிடிக்கமொட்றடன் 
ஆ) முன்பு புககபிடித்றதன் 
இ) எப்தபொழுதவது புககபிடிறபன் 
ஈ) ததொடர்ந்து புககபிடிறபன் 
2 ஒருநொகளக்கு எத்தகன பீடி/ ெகீிதரட் பிடிப்பீர்கள் 
அ) 1-9 
ஆ) 10-19 
இ) 20 க்குறமல் 
3 றநொயின் கொல அளவு 
அ) 1-3 வருடம் 
ஆ) 4-6 வருடம் 
இ) 7-9 வருடம் 
ஈ)  >10 வருடம் 
4 முன்பு எத்தகன முகறகள் இந்த நொட்பட்ட இறுக்கமொன நுகரயீரல் 
றநொய் உள்ளது 
அ) 1-3 முகற 
ஆ)  4-6 முகற 
இ)  7-9 முகற 
ஈ)  >10 முகற 
5 மருத்துவமகனயில் அனுமதிக்க அறிகுறிகள் 
அ) ததொடர் இருமல் 
ஆ) ததொடர் இளப்பு 
இ) மூச்சு திணறல் 
ஈ) றமல் கூறிய அகனத்தும் 
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6 கொல அதிகரித்தல் 
அ) மகழ கொலம் 
ஆ) பனி கொலம் 
இ) றகொகட கொலம் 
ஈ) குறிப்பிட்டுயில்கல 
7 றநொய் அதிகரிக்க பிற தூண்டுதல்கள் 
அ) உடல் மற்றும் மனஅழுத்தம் 
ஆ) உயிரி எரிதபொருள் 
இ) கொற்று மொசுபொடு 
ஈ) சுவொெ ததொற்று 
8 தூக்கமின்கம கொரணம் 
அ) நொள்பட்ட இருமல் 
ஆ) மூச்சு திணறல் 
இ) தநஞ்சு வலி 
ஈ) மற்ற கொரணம் 
9 உடன் றநொய்கள் 
அ) இருதய றநொய் 
ஆ) நீரிழிவு றநொய் 
இ) சுவொெ றநொய் 
10 ெிகிச்கெ முகறகள் 
அ) நுகரயீரல் மருந்துகள் 
ஆ) சுவொெமருந்துகள். 
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பகுதி - 2 
அறிமுகம்:- 
கீழ்க்கொணும் நிபந்தகனகளுக்கு ஏற்றவொறு தபொருத்தமொன பதிலில் டிக் 
குறிகவக்கவும். 
உளவியல் நன்கு இருப்பது:- 
1- எப்றபொதும் இல்கல, 2- எப்தபொழுதொவது இருக்கும், 3-  எல்லொ 
றநரங்களிலும் இருக்கும். 
உடல்நலம், உணர்ச்ெி, ெமூகமற்றும்ஆன்மீகம் நன்குஇருப்பது:- 
1– கடினம் இல்கல, 2– ெில றநரங்களில் கடினம், 3 – மிகவும் 
கடினம். 
வ.எண் அடிப்பகட 1 2 3 
I)  
உளவியல் 
நன்கு இருப்பது 
எப்றபொதும் 
இல்கல 
எப்தபொழுதொவது 
இருக்கும் 
எல்லொறநரங்களிலும் 
இருக்கும் 
1 பகல்/ எல்லொ 
றநரத்திலும் 
இருமல் 
தநருக்கடி’ 
   
2 தநஞ்ெில் கபம் 
இருக்கிறது 
   
3 தநஞ்ெில் 
இருக்கமொக 
இருப்பது 
தூங்க 
முடியவில்கல 
   
4 ஆழ்ந்து உறங்க 
முடியவில்கல 
   
5 ஏறதொ ஒரு 
கொரணத்தினொல் 
மூச்சுதிணறல் 
   
6 இளப்பு    
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7 கடுகமயொக 
அதிகரித்தல் 
(ஏறதொ ஒரு 
கொரணத்தினொல் 
கடுகமயொக 
அதிகரித்தல்) 
   
8 றெொர்வொக 
உணர்தல் 
   
9 கொகலயில் 
எழுந்திருப்பது 
கடினம் 
   
10 ததொயிவொக 
உணர்தல் 
   
 
 
II) உடலியல் நன்கு இருப்பது 
1  
கடினம் 
இல்கல 
2           
ெில 
றநரங்களில் 
கடினம் 
3 
மிகவும் 
கடினம் 
11. 
 
வொழ்வின் அன்றொட 
றவகலககள தெய்ய 
முடியவில்கல 
   
12. தபொழுதுறபொக்கு நிகழ்விகள் 
தெய்வதில் பிரச்ெகன 
   
13. ஆறரொக்கிய மற்றது றபொல் 
உணர்தல் 
   
14. ஆழ்ந்து உறங்கமுடிகிறது    
15. பெியின்கம    
III) உணர்ச்ெி நன்கு இருப்பது    
16. பிறகற ெொர்ந்து இருப்பது 
றபொல் உணர்தல் 
   
17. ஓய்தவடுக்க கடினமொக 
உள்ளது 
   
18. பயன் அற்று இருப்பது றபொல் 
உணர்தல் 
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19. றெொகமொகவும் மற்றும் 
மனறெொர்வொகவும் உணர்தல் 
   
IV) ெமூக நன்கு இருப்பது    
20. குடும்பத்தில் இருந்து 
றமொெமொன ஆதரவு 
   
21. நிதி ெிக்கல்கள்    
22. குடும்பத்கத கவனிப்பது 
கடினம் 
   
23. குகறந்த சுயமரியொகதகய 
உணர்கிறறன் 
   
V) ஆன்மீகம் நன்கு இருப்பது    
24. மதநிகழ்வுகள் வொழ்க்ககக்கு 
முக்கியம் இல்கல 
   
25. மதநடவடிக்கககளில் கவனம் 
தெலுத்த முடியவில்கல 
   
 
 
 
 
 

 மனதை ஒரு நிதைப்படுத்ை வேண்டும்.
 சவுகரிமான ஆதை அணிய வேண்டும்.
 பயிற்சியின் வபாது கடுதமயாக உணர்ந்ைால் பயிற்சிதய
நிறுத்தி ககாள்ளவும்.
பயிற்சிக்கு முன் நீர் அருந்தி ககாள்ளவும்.
1) உைடு சுோச பயிற்சி –
 படி 1- நிமிர்ந்து உட்கார்ந்து கழுத்து மற்றும்
வைாள்பட்தை ைதசகதள ைளர்த்ை வேண்டும்.
 படி 2 - ோய்தய மூடி ககாண்டு மூக்ினன்
ேழியாக, 2வினாடிகளுக்கு சாைாரணமாக
சுோசிக்கவும்.
 படி 3- உைடுகதள மூடி ககாண்டு 4
வினாடிகளுக்கு மூச்தச கேளியிைவும்.
 படி 4- ஒரு நிமிைம் படி 1-3 மீண்டும்
கசய்யவும்.
 படி 1-வேராக படுத்துக்ககாண்டு உங்கள்
முழங்கால் மற்றும் ைதையின் கீழ்
ைதையதணகள் தேத்து ககாள்ளவும்.
 படி 2- உங்கள் கைாப்தபயின் மீது ஒரு
தக தேக்கவும், உங்கள் கேஞ்சு பகுதியில்
மற்வ ாரு தக தேக்கவும்.
 படி 3- 3 விோடிகள் மூக்கு ேழியாக ஆழமாக
உள்ளிழுக்கவும்.
 படி 4- ேயிற்று ைதசகதள இருக்ின
ககாண்டு, காற்த உைடு ேழியாக கமதுோக
கேளிவிைவும்.
 படி 5- இந்ை பயிற்சிதய 5 முைல் 10 
கசய்யவும்.
 படி 1- உங்கள் ோதய மூடி தேத்து
ககாண்டு கூர்தமயாக மூக்ினன் ேழியாக
காற்த உள்ளிழுக்கவும்.
 படி 2 -கமதுோக உங்கள் ோய் ேழியாக
காற்த கேளிவிடும், 2-3 விோடிகள்.
 படி 3- ஒரு நிமிைத்திற்கு படி 1-2தய
திரும்ப கசய்யவும்.
ேதளந்து ககாடுக்கும் உைற்பயிற்சி.
1) கைாதையின் முன் பகுதிதய நீட்டிக்க:
 படி 1-சுேரில் இருந்து சற்று ைள்ளி
நின்று ககாண்டு, உங்கள் இைது தகதய
சுேற்றின் மீது தேக்கவும்.
 படி 2- வேராக நின்று ககாண்டு, ேைது
தகதய ககாண்டு, இைது கால்
பிடித்துக்ககாள்ளவும்.
 படி 3- உங்கள் குதிகால் பகுதிதய பின்
வோக்ின இழுக்கவும்.
 படி 4- 10 முைல் 20 விோடிகள் தேத்திருங்கள்.
 படி 5- மறுபடியும் மறுபக்கம் கசய்யவும்.

 படி 1- நின்று அல்ைது அமர்ந்து ககாண்டு
உங்கள் முதுகு பகுதி வேராக
தேத்துக்ககாள்ளவும், ேைது தகதய
வைாள்பட்தையின் எதிராக நீட்டி இைது தகதய
பிடிக்கவும்.
 படி 2- உங்கள் முழங்தகதய கேஞ்சுக்கு
பக்கோட்டில் இழுக்கவும்.
 படி 3- ஒரு நிமிடம் ேதர பிடிக்கவும்.
 படி 4- ஒவ்கோரு தகயில் 3 ைைதே மீண்டும் கசய்யவும்.
 படி 5- மற்க ாரு உள்ளங்தகதய நீட்டி மறுபடியும் 3 முத 
மற்க ாரு தகக்கு கசய்யவும்.
 படி 1- அமர்ந்து அல்ைது வேராக நின்று
ககாண்டு ஒரு தகதய உங்களுக்கு
முன்பாக நீட்டி உங்கள் உள்ளங்தகதய
கீழ் வோக்ினயபடி தேக்கவும்.
 படி 2- உள்ளங்தகயின் பின் பகுதிதய
உங்களுக்கு வேராக மைக்கவும்.
 படி 3- முழங்தகயில் நீட்டிதப உணருைல்.
 படி 4- ஒரு நிமிைத்துக்கு அப்படிவய
தேத்து ககாள்ளவும்.
 படி 5- மற்க ாரு உள்ளங்தகதய நீட்டி
மறுபடியும் 3 முத மற்க ாரு தகக்கு
கசய்யவும்.
 படி 1 : அமர்ந்து அல்லது 
நேராக ேின்று ககாண்டு 
ஒரு கககை 
உங்களுக்கு முன்பாக 
ேீட்டி உங்கள் 
உள்ளங்கக நமல் 
நோக்கி இருக்கும் படி 
கைக்கவும்.
 படி2: ேீட்டிை ககைின் ைிரல்ககள 
மற்க ாரு ககைின் உதைிநைாடு 
ைிரகல கீழ்நோக்கி மடக்கவும்.
 படி 3 : முழங்ககைில் ேீட்டிப்கப 
உணருத்தல்.
 படி 4 : 1 ேிமிடாத்துக்கு அப்படிநை 
கைத்து ககாள்ளவும்.
 படி 5 :மற்க ாரு உள்ளங்கககை 
ேீட்டி மறுபடியும் 3 முக 
மற்க ாரு ககக்கு கெய்ைவும்.
 படி 1 : நேராக ேின்று
(அ) அமர்ந்து ககாண்டு
பாதத்கத தகரைில் 
படும்படி கைக்கவும்.
 படி 2 : உங்கள் 
தகலகை ஒருபக்கமாக 
ொய்க்கவும்.
 படி 3 : மற்க ாரு ககக்கு 
எதிராக தகலகை 
ொய்க்கவும்.
 படி 4 :ொய்ந்த கழுத்தின் 
எதிர்பகுதிைில் 
ைலுப்படுத்தகல 
உணருதல்.
 படி 5 : இந்த 
கெய்முக கை ஒரு 
முக  ேிறுத்தவும் 
1) கால் ேீட்டிப்பு பைிற்ெி:
 படி 1 : நேராக அமரவும்.
 படி 2 : ெவுகாரிகமாக 
ககககள முழங்காலுக்கு 
நமல் கைத்து 
ககாள்ளவும்.
 படி 3 : உங்கள் 
பக்கைாட்டின் இருக்கும் 
கககளின் உதைிநைாடு
ோற்காலிைின் இருந்து 
எழும்ப நைண்டும்.
 படி 4 : இநத ேிகலைில் 1௦ 
ைினாடிகள் கைக்கவும்.
 படி 5 : பகழை ேிகலக்க
ககாண்டு ைரவும்.
 படி 6 : ோன்கு முக  
மறுகாலுக்கு கெய்ைவும்.
 படி 1 : உங்கள் 
ோற்காலிைின் உதைி
ககாண்டு நேராக 
ேிற்கவும்.
 படி 2 : ஒரு காகல 
பின்நோக்கி 
உகதக்கநைண்டும்.
 படி 3 : பழைய நிழைக்கு 
கால்கழை ககாண்டு 
வரவும்.
 படி 4 : நான்கு இரண்டு
கால்களுக்கு கெய்யவும்.
 படி 1 : நேராக ேின்று
ககாண்டு, உங்கள் 
ககககள பக்கைாட்டில் 
கைக்கவும்.
 படி 2 : ஒரு 
முழங்காகல 
உைர்த்தவும்.
 படி 3 : பகழை ேிகலக்கு
காகல ககாண்டுைரவும்.
 படி 4 : மறுபடியும் ோன்கு 
முக  இரு கால்களுக்கு 
கெய்ைவும்.
 படி 1- நேராக உங்கள் 
ககககள ஒரு சுைரில்
அல்லது ஒரு
ோற்காலிைின்
பின்பு த்தில் கைக்கவும்
 படி 2- ஒரு கால் உைர்த்தி, 
பின்னால் இருந்து, உங்கள்
கால் தகரைில் 
இகணைாக கைக்கவும்.
 படி 3- கால் திரும்ப அதன்
முந்கதை ேிகலைில்
கைக்கவும்.
 படி 4- ஒவ்கைாரு காலிலும் 
4 முக  திரும்ப கெய்ைவும்.
 படி 1 : நேராக அமர்ந்து
முழங்கால் மற்றும் பாதம் 
தகரைில் படும்படி 
ெவுகரிைமாக உட்காரவும்.
 படி 2 : குதிகாகல 
உைர்த்தவும்.
 படி 3 : பகழை ேிகலக்கு
காகல ககாண்டு ைரவும்.
 படி 4 : ோன்கு முக 
இரண்டு கால்களுக்கு
கெய்ைவும்.
  
 
 
 
APPENDIX - G 
 
Lung reconstruction and rehabilitation 
programs 
 1) Hazardous of smoking 
 Effects of tobacco are strokes, heart 
attacks, lung cancer. 
 Toxicity in the lungs. 
 Blood pressure can cause chest 
pain. 
 
Stop smoking 10 commands:- 
 Tobacco and tobacco products 
should be kept hidden. 
 When the tobacco memory is 
remembered, you should go to a different place. 
 To drink water often. 
Use chocolate, carrot, snacks instead of 
tobacco. 
  
 Frequent breathing should be 
done. 
 
 Exercise should reduce tobacco 
effect. 
 
 You should remember your 
future when you use tobacco. 
 
 Tobacco should be abandoned 
on the first day of planning, indicating a date 
for stopping tobacco habits. 
 
 To be confident that God can stop 
him. 
 Tobacco stop friends are good 
friends. 
  
2) Note about foods: 
 Take 3 high-yielding foods. 
 Avoid fatty foods. 
 
 Take oranges and lettuce. 
 
 Avoid eating sweets. 
 
 Reduce the amount of salt in 
the diet. 
 
 Do not eat more food at the same time. 
 Drink 6-8 glass of water. 
 Avoid potato and hazelnuts 
Take the protein rich foods.(eg) milk, eggs, 
fish, beans 
 3) Effects of abandonment of medication: 
 
 Very severe chest pain. 
 Breathing problems will be caused if you 
continue to get a breath taking. 
 If continue skipping medicines it 
will leads to respiratory arrest. 
 
4) Methods to prevent frequent lung problem: 
 Avoid traveling to tobacco. 
 
 Infection vaccine reduces mortality 
rate. 
 
 Take the given pills. 
 
 
 
 Wash hands well (before food 
and medicine). 
 
 Keep the living room clean. 
 
 Chemical products do not use at 
home. (Air cleansers, perfume products). 
 Avoid heavy smells. 
 Avoid traveling to places 
where crowded. 
 Ask how to get rid of the lung infection shaft. 
 Ate the right food at the right 
time. 
 
 
